Structural dynamics of retroviral genomes by Grohman, Jacob K.
  
STRUCTURAL DYNAMICS OF RETROVIRAL GENOMES 
 
Jacob K. Grohman 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill 
in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 
Department of Biochemistry and Biophysics. 
 
 
Chapel Hill 
2012 
 
 
 
 
 
             Approved by: 
                                                             Kevin M. Weeks, Ph.D. 
                                                               Howard M. Fried, Ph.D. 
                                                                 Jason D. Lieb, Ph.D. 
       Nancy Allbritton, Ph.D. 
                                                 Ron Swanstrom, Ph.D. 
 
 ii 
 
 
 
ABSTRACT 
JACOB K. GROHMAN: Structural Dynamics of Retroviral Genomes 
(Under the direction of Kevin M. Weeks) 
 
Retroviral RNA genomes form myriad structures that are governed by critical 
interactions with either the nucleocapsid (NC) protein or the nucleocapsid domain of Gag 
polyprotein. I have pioneered two powerful technologies, based on SHAPE (selective 2’-
hydroxyl acylation analyzed by primer extension), to explore interactions between NC and the 
RNA genomes of the xenotropic murine leukemia virus related virus (XMRV) and the Moloney 
murine leukemia virus (MuLV). In the first approach, ultra-sensitive SHAPE, I developed a 
two-color capillary electrophoresis instrument with low attomole (10-18) sensitivity. New 
analysis approaches and the high sensitivity of this instrument allowed me to obtain 
unprecedented single-nucleotide resolution structures from authentic RNA genomes of MuLV 
and XMRV. In the second approach, time-resolved SHAPE, I used a fast acting SHAPE 
reagent to reveal the structural biogenesis of NC binding to the MuLV retroviral RNA genome. 
The data generated using these SHAPE-based technologies allow me to propose detailed 
mechanisms for both the specific RNA binding and the chaperone activities of NC. 
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"We're surrounded. That simplifies the problem!"  
                                                                                
                                                                  -Chesty Puller, USMC 
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CHAPTER 1 
INTRODUCTION 
 
 1.1 The role of retroviral RNA genomic structure in viral replication. 
 RNA structure plays an integral role throughout the replication cycle of all 
retroviruses (Figure 1.1),1,2 including serious pathogens like Human Immunodeficiency Virus 
(HIV)3 and Human T-cell Leukemia Virus (HTLV).4,5 Aside from encoding viral proteins, the 
retroviral RNA genome must interact on a structural level with several cellular and viral 
components, including Gag and Nucleocapsid (NC) proteins.6 Two distinct examples of 
genomic RNA structure auto-regulating its replication occur during (i) genomic RNA 
dimerization and (ii) packaging (Figure 1.1). (i) Retroviral genomes are composed of two 
identical copies of genomic RNA joined by base pairing and tertiary interactions in a 
noncoding region near the 5' ends of the two RNA genomes (Figure 1.2).7-9 Once formed, 
the RNA dimer regulates reverse transcription, genomic recombination, and encapsidation 
of the genome into nascent viral particles (virions).10,11 In vitro dimerization is greatly 
accelerated in the presence of the nucleocapsid (NC) protein,12 which is copackaged with 
the viral RNA. The precise structural mechanism of dimer formation remains unknown. (ii) 
The genomic RNA destined for assembling new virions appears to be recognized 
structurally as a dimer.13,14 Dimeric recognition ensures that exactly two copies of MuLV 
genomic RNA are packaged into every virion. The genomic RNA dimer is packaged into 
immature nascent virions15. The RNA is likely bound to the nucleocapsid domain of Gag in a  
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Figure 1.1 Overview of the retroviral replication cycle. Processes involving RNA 
conformational changes are emphasized in red. Key stages are labeled. 
  
 
 
 
3 
circular configuration within the immature virion (Figure 1.1). After budding from the host 
cell, Gag polyprotein undergoes viral protease-mediated cleavage.16 The cleavage of Gag 
initiates dramatic structural changes of the virion, including changes in RNA structure and 
localization, to create the mature (infectious) particle (Figure 1.1).  Since, only the mature  
virus is infective,16 RNA structural changes have been proposed to be an important part of 
maturation. Genomic RNA structure of immature MuLV has not been characterized and only 
bulk measurements of global structure are currently available to provide information for 
distinguishing between the immature and mature MuLV particles. This limitation is based 
largely on the extraordinary difficulty of producing enough RNA to perform structural 
analysis. 
 An intimate understanding of how retroviral RNA effects its own fate during the 
replication cycle requires analysis of RNA structure both inside authentic viruses and during 
critical conformational changes.  However, current technologies for understanding RNA 
structure are inadequate because they require amounts of RNA that are one thousand to 
one million-fold greater than that which is normally recoverable from virions and infected 
cells. 
1.2 SHAPE Chemistry. 
 My lab has developed a quantitative chemistry to probe RNA structure known as 
Selective 2'-Hydroxyl Acylation analyzed by Primer Extension, or SHAPE.17,18 SHAPE 
technology maps RNA structure in a simple two-step process, (i) RNA modification and (ii) 
primer extension. In the first step, exposure to electrophilic SHAPE reagents, like 1-methyl-
7-nitroisatoic anhydride (1M7),19 acylate the 2' hydroxyl of reactive RNA nucleotides creating 
2'-O-adducts. Because every RNA nucleotide has a 2' hydroxyl, every nucleotide is  
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Figure 1.2 The gammaretroviral genomic dimer. Retroviruses package two identical copies 
of their genome into nascent infectious particles, or virions. Retroviral genomic RNA forms 
a dimeric structure by noncovalent interactions near their 5´ ends. 
  
 
 
 
5 
interrogated. The acylation reaction preferentially modifies flexible RNA nucleotides (Figure 
1.3a).   Flexible   RNA   nucleotides   are most often located  in  single-stranded regions of 
RNA. The second step of SHAPE is primer extension of the modified RNA (Figure 1.3b). 
Fluorescently-labeled primers are used in a reverse transcription reaction to create a 
fluorescently-labeled structure-specific cDNA library20. The cDNA library is structure-specific 
because RNA adducts create stops in reverse transcription exactly one nucleotide prior to 
RNA modification. Therefore, the length of the cDNA corresponds to a position of 
modification on the RNA. A prevalent cDNA length therefore indicates a highly reactive RNA 
nucleotide located in a flexible, or single-stranded region of RNA. The labeled cDNA 
molecules are then separated in a single capillary of a DNA sequencer (Figure 1.3c, left 
panel). Each SHAPE experiment also includes a no reagent control and sequencing ladders 
to relate elution time to sequence. The resulting data, a plot of reactivities as a function of 
nucleotide position (Figure 1.3c, right panel), is used to propose and confirm RNA 
structures, locate protein binding sites, and monitor structural rearrangements.21 I use the 
single nucleotide resolution SHAPE reactivities to create secondary structure “snapshots” of 
RNA (Figure 1.3d). This is done by inputting SHAPE reactivities as constraints into 
RNAstructure,22 a folding algorithm that output secondary structures. 
1.3 SHAPE requires a large amount of RNA. 
 SHAPE has been successful in analyzing many important retroviral RNA 
structures, Including the Moloney Murine Leukemia virus (MuLV),23,24 but its uses have been 
limited in virio by the lack of the ability to detect small amounts of RNA. Like traditional 
probing experiments, SHAPE requires at least 3 pmols of RNA per experiment (Figure 1.4),  
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Figure 1.3  SHAPE chemistry. 
  
 
 
 
7 
which is 100,000 times more than what is easily isolatable. Therefore, the major hurdle is 
improving detection of the unique cDNAs to effect SHAPE on miniscule amounts of RNA. 
1.4 Time-resolved SHAPE technology. 
  RNA structural transitions are an important aspect of cellular function and information 
transfer.25 Dynamic regions within RNA molecules are often interaction sites for small 
molecules, proteins, and other RNAs.26 Besides classical biochemical methods performed in 
conjunction with mutational data,27 there are very few technologies adept at studying RNA 
conformational changes. With the advent of better structural technologies, including x-ray 
footprinting,28 oligonucleotide hybridization, and time-resolved NMR studies,29 however, the 
RNA structure field has experienced exponential growth. A new SHAPE-based technology, 
developed by my lab has also contributed to our ability to study RNA in motion. 
Time-resolved SHAPE (TR-SHAPE), is a recently developed SHAPE-based technique for 
temporal structural and mechanistic studies of RNA.30 In TR-SHAPE, a fast acting SHAPE 
reagent, benzoyl cyanide (BzCN), reacts by one of two pathways: 1) forms a 2’-O adduct 
with a flexible nucleotide or 2) rapidly self-inactivates by hydrolysis (0.25s half life).31 TR-
SHAPE can be used to take single second snapshots of RNA structure at single nucleotide 
resolution.  
1.5 Research overview: development and application of two SHAPE-based 
technologies. 
 In this dissertation, I attempt to advance the field of RNA structural technologies with 
the development and application of two SHAPE-based technologies, ultrasensitive (US) and 
time-resolved  (TR) SHAPE. In the second chapter, I create ultrasensitive SHAPE, which  
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Figure 1.4 RNA abundance. Molar amounts of RNA obtained from different biological 
sources are shown in gray. Large colored ovals indicate the amount of RNA required for 
conventional and ultra-sensitive capillary electrophoresis technologies. The red arrow 
emphasizes the discrepancy between the amount of RNA obtainable and the amount 
required for structural analysis 
 
 
 
 
 
 
 
  
 
 
 
9 
has a sub-femtomole SHAPE sensitivity, more than four orders of magnitude more sensitive 
than traditional SHAPE. This technology allows me to create structural models of MuLV and  
XMRV within virions, as they interact on a structural level with Gag and NC proteins. In the 
third chapter, I apply US-SHAPE to create the first structural snapshot of MuLV genomic 
RNA packaged within nascent immature virions. In the fourth chapter, I advance a recent 
technology, time-resolved SHAPE, by creating an RNA “movie” of MuLV genomic RNA 
dimerization both with and without NC protein.  
1.5.1 Ultra-sensitive (US) SHAPE 
  Most single-nucleotide resolution RNA structure determination technologies cannot 
be used to analyze RNA from scarce biological samples, like viral genomes. To make 
quantitative RNA structure analysis applicable to a much wider array of RNA structure-
function problems, I developed and applied ultra-sensitive selective 2'-hydroxyl acylation 
analyzed by primer extension (US-SHAPE) to structural analysis of authentic genomic RNA 
of the xenotropic murine leukemia virus-related virus (XMRV) (Figure 1.5).32 For analysis of 
fluorescently labeled cDNAs generated in ultra-sensitivity SHAPE experiments, I developed 
a two-color capillary electrophoresis approach with zeptomole molecular detection limits and 
sub-femtomole sensitivity for complete SHAPE experiments involving hundreds of individual 
RNA structure measurements. Ultra-sensitivity SHAPE data correlated closely (R = 0.89) 
with data obtained by conventional capillary electrophoresis. Using US-SHAPE, I 
determined the dimeric structure of the XMRV packaging domain, examined dynamic 
interactions between packaging domain RNA and viral nucleocapsid protein inside virion 
particles, and identified the packaging signal for this virus (Figure 1.5). Despite extensive 
sequence differences between XMRV and the intensively studied Moloney murine leukemia 
virus, architectures of the regulatory domains are similar and reveal common principles of 
gamma retroviral RNA genome packaging. 
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Figure 1.5 Ultra-sensitive SHAPE technology. Designed for the analysis of low-copy 
number authentic RNAs, the molecular and SHAPE sensitivities are shown.  US-SHAPE has 
been used to determine the dimeric structure of the XMRV packaging and regulatory domain 
and located nucleocapsid (NC) binding sites within virions. 
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1.5.2 Secondary structure of MuLV genomic RNA within the immature virion. 
    Retroviruses package a structurally distinct dimeric RNA genome into 
noninfectious immature virions.7,15 However, analysis of this structure is complicated by the 
relative scarcity of authentic retroviral RNA. In this chapter, I use ultra sensitive SHAPE (US-
SHAPE) to obtain unprecedented structural information about the dimerization and 
packaging regulatory domain of the immature Moloney murine leukemia virus (MuLV) 
genomic RNA, both in virio and ex virio. I find a key structural difference within the 
palindromic sequence, PAL2, of immature viral RNA relative to mature viral RNA. In mature 
infectious MuLV particles, PAL2 forms an intermolecular duplex. However, in immature 
virions the PAL2 sequence is instead sequestered in an intramolecular stemloop. These US-
SHAPE-derived structural models suggest that immature MuLV RNA is packaged into a 
kinetically-trapped intermediate state. The introduction of a MuLV mutant into authentic 
viruses in which the PAL2 domain is replaced with a string of adenosine residues alters the 
structural spacing in this region and displays a 10-fold decreased infectivity compared to 
native RNA. 
1.5.3 A Guanosine-Centric Mechanism for RNA Chaperone Function. 
 
 Proteins with generalized, ATP-independent, RNA chaperone activity ubiquitously 
facilitate the RNA conformation changes and strand annealing steps required for essentially 
all the highly dynamic and structurally complex processes involving RNA.33 The requirement 
for RNA chaperone activity is related, in part, to fundamental features of RNA structure. 
RNA structures are built up from only four fundamental building blocks such that many folds 
are compatible with a given sequence and misfolded structures are thermodynamically 
stable, creating long-lived intermediates.34,35 However, a mechanistic understanding of the 
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widespread requirement for RNA chaperone function is unclear. The retroviral nucleocapsid 
(NC) proteins are paradigmatic RNA chaperones and are essential for many steps of 
retroviral replication including genome dimerization,36 which enables specific packaging of 
two genomes into each virion. In this chapter, I use time-resolved selective hydroxyl 
acylation analyzed by primer extension (TR-SHAPE) to understand the effects of 
nucleocapsid on dimerization of the minimal dimerization motif of M-MuLV. TR-SHAPE 
allows second-scale resolution of conformational changes in RNA molecules. Over a 600-
second timeframe, we find that the naked RNA undergoes four distinct time-dependent 
transitions over the course of dimerization (Figure 1.6a). Using model-free clustering, we 
discover that the entire data set, encompassing over 2700 single-nucleotide measurements, 
can be grouped into seven distinct time-dependent transitions that occur at four rates 
(Figure 1.6b). I find that dimerization of the Moloney murine leukemia virus (MuLV) genome 
proceeds via a complex mechanism characterized by multiple slow steps (Figure 1.6c). In 
the presence of the retroviral NC protein, the rate-limiting steps of dimerization collapse to a 
single, fast kinetic step. The initial interaction between NC and RNA primarily involves 
interactions with guanosine nucleotides, which forms the strongest, and most promiscuous, 
base pairs in any RNA. Substituting the more weakly pairing inosine for guanosine yields an 
RNA that folds rapidly, and in an NC-independent way, the same final structure as the native 
RNA. From this analysis, I propose a comprehensive dimerization model for 
gammaretroviruses, including a mode of action for the nucleocapsid chaperone protein. 
1.6 The point: Biological impact of SHAPE-based structure technologies 
    Dimerization of genomic RNA is a critical step in nearly all retroviral infections and 
occurs against an enormous background of cellular RNAs. A mechanistic understanding of 
the dimerization process, with and without its copackaged nucleocapsid (NC) chaperone, is 
key to discovering the source of this specificity. Until now, a mechanistic understanding of 
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Figure 1.6 Time-resolved SHAPE technology. (a) Time-resolved reactivity profile of MuLV 
RNA dimerization. (b) K-means clustering of seven time-dependent behaviors. (c) MuLV 
genome dimerization proceeds via a complex mechanism characterized by multiple slow 
steps.  
 
  
  
 
 
 
14 
retroviral dimerization was intractable because RNA structural technologies were inept at 
studying RNA in motion. In chapter 4, I advance a SHAPE-based technology, time-resolved 
SHAPE  (TR-SHAPE), to create the first ever "molecular movie" of RNA dimerization as it 
binds to NC. From this work, I discover a general mechanism for ATP independent RNA 
chaperone activity in which non-specific chaperones destabilize interactions between 
guanosine and other nucleotides to smooth out the RNA folding landscape. This mechanism 
appears to apply to diverse RNA chaperones and is related to fundamental features of RNA 
thermodynamics. It is likely that this generalized molecular mechanism of RNA chaperones 
will lead to novel approaches at preventing viral pathogenesis. 
   Specific genomic dimerization is the cornerstone for proper packaging into nascent 
retrovirions. Armed with a mechanistic, single-nucleotide resolution framework of how the 
genomic RNA dimer is formed, I next set out to understand how the dimeric structure 
interacts with its protein counterparts to form the simplest diploid organism, the infective 
retroviral virion. To fully understand the role of RNA conformational changes in retroviral 
biology, I needed to understand RNA structure and RNA-protein interactions within authentic 
virions.  
   Preliminary exploratory experiments have demonstrated that I can use SHAPE 
chemistry to map the equilibrium structure of mature MuLV RNA within authentic virions.24,37 
Strikingly, within the scanty 2% of the entire MuLV genome that was analyzed in virio, we 
detected specific differences in the structure of the mature genomic RNA inside viruses 
compared to the same protein-free extracted RNA. In chapters 2 and 3, I complement this 
work with the advent of ultra-sensitive SHAPE technology, designed for the analysis of 
scarce amounts of RNA extracted from authentic biological sources and within virions. Our 
results verify the packaging and regulatory signal RNA exists in a structurally distinct 
conformation in the immature state and I have created secondary structure models of the 
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RNA within this state. A mutant viral construct designed to mimic the immature state, with a 
structurally distinct dimerization domain element, was introduced into authentic viruses and 
found to exhibit a ten-fold deficiency in genomic replication. US-SHAPE-derived structural 
models and in vivo results suggest that immature MuLV RNA is packaged into a stable 
intermediate state. From these models, we have a more comprehensive understanding of 
how retroviruses package their genomic material and create infective progeny.  
    The future of this work will most likely involve the marriage of the two technologies, 
US-SHAPE and TR-SHAPE. The ability to develop single-nucleotide resolution structural 
models and conformational mechanisms within cells and infected virions will likely supplant 
analysis of artificial constructs and allow real time visualization of the replication of all RNA 
viruses. 
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CHAPTER 2 
FEMTOMOLE SHAPE REVEALS REGULATORY STRUCTURES IN THE 
AUTHENTIC XMRV GENOME 
  
2.1 The role of SHAPE in retroviral genomic RNA structure.  
As is likely to be the case for essentially all coding and non-coding RNAs, higher-
order secondary and tertiary structures in viral genomes play numerous roles in 
replication.1-3 High-throughput selective 2'-hydroxyl acylation analyzed by primer extension 
(SHAPE) makes possible characterization of RNA structure at single-nucleotide resolution 
on the kilobase scale and has proven to be a powerful approach for understanding 
structure-function relationships in RNA.4-7 In a SHAPE experiment, conformationally 
flexible (generally single-stranded) nucleotides react with 1-methyl-7-nitroisatoic anhydride 
(1M7),8 or another electrophilic SHAPE reagent,9,10 to create a covalent 2'-O-ribose adduct 
(Figure 2.1a). Sites of adduct formation are detected by primer extension using 
fluorescently labeled primers. SHAPE primer extension products can be separated on 
commercially available capillary electrophoresis sequencing instruments11,12 resulting in an 
electropherogram in which peak intensities correlate with local flexibility at each individual 
nucleotide in the RNA (Figure 2.1b).13 These data are processed to yield a reactivity profile 
for every RNA nucleotide (Figure 2.1c). SHAPE has been validated by analysis of RNAs 
with known structures and was used to discover structure-function relationships in an 
entire HIV-1 genome,5,11 and in regulatory domains in the Moloney murine leukemia virus 
(MuLV).14,15 
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Figure 2.1 SHAPE overview. (a) Mechanism of RNA SHAPE chemistry. Hydroxyl-
selective electrophiles modify the 2'-OH group of flexible RNA nucleotides (red) to create a 
2'-O-adduct. (b) Subsequent detection of 2'-O-adducts by primer extension and separation 
by capillary electrophoresis yields an electropherogram of fluorescent peaks. Peak 
volumes correspond to SHAPE reactivity. (c) Integrated peak intensities after background 
subtraction.  
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2.2 The sensitivity of SHAPE. 
The sensitivity of SHAPE is limited by the generally poor detection limits of 
conventional capillary electrophoresis instrumentation and requires ~3 pmol of RNA per 
experiment.4 This limitation is significant: Tens of liters of infected cells in a highly 
optimized cell culture system were required to obtain sufficient genome copies (~100 
pmol) for analysis of an entire HIV-1 genome.5 High levels of background noise from  
light scattering, leakage of excitation light, and electronic noise reduce the ability of 
conventional instruments to detect fluorescently-labeled primer extension products.16 
When optimized for low-abundance species, capillary electrophoresis is, in principal, 
capable of detecting single molecules.17 
To address the challenge of analyzing rare, biologically important RNAs, we have 
developed an ultra-sensitive RNA structure analysis platform that employs a two-color 
capillary electrophoresis instrument with zeptomole (10-21) instrument detection limits and 
sub-femtomole sensitivity for complete SHAPE experiments comprised of hundreds of 
individual structure measurements. Here we describe application of this technology to 
analysis of a low-abundance gammaretrovirus, xenotropic murine leukemia virus related 
virus (XMRV).18 Although XMRV is not likely to be a human pathogen,19,20 as originally 
reported,18,21 this virus is an excellent example of a recently identified infectious agent 
currently available in only low amounts. XMRV is evolutionarily related to the well-
characterized MuLV,22-25 suggesting that critical features of its structure and biology are 
conserved. Here, we used high-sensitivity SHAPE to analyze scarce XMRV RNA gently 
extracted from virions and inside viral particles. Despite extensive sequence differences 
between XMRV and the MuLV, the regulatory domain architectures are similar, revealing 
universal principles of retroviral RNA genome packaging. 
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2.3 Design and construction of an ultra-sensitive capillary electrophoresis 
instrument. 
 We sought to improve the detection limits of SHAPE experiments by designing and 
building a robust, yet highly sensitive, capillary electrophoresis instrument. A single-mode 
fiber optic cable with an integrated lens was used to focus the light from a dual color argon 
laser (488 and 514 nm) onto a capillary (Figure 2.2). The optical fiber enabled the laser to 
be placed at a distance and ensured robust alignment of the laser beam. A high-numerical 
aperture microscope objective oriented at a right angle to the laser beam collected light 
from the capillary and minimized collection of scattered excitation light. The microscope 
objective was mated to an optical cube (Figure 2.2) with a dichroic filter to reflect green 
wavelengths while transmitting yellow light. Collection lenses mounted into the cube 
focused the light onto a multimode optical fiber that acted as a spatial filter to remove 
scattered light and transfer fluoresced light to the detector. Once the optical path was 
aligned, the cube rigidly maintained the positions of the various components so that 
realignment was required infrequently. Filters specific for each fluorophore were placed 
between the optical cube and the detector photomultiplier tubes. The multimode fibers 
permitted the detectors to be placed at a distance from the optical cube facilitating 
alignment of the optical system and minimizing interference from high voltage capillary 
electrophoresis. The melding of these individual innovations yielded a robust and reliable 
optical system for the study of RNA structure. 
2.4 Detection limits for free fluorophores and for a complex SHAPE library. 
 The limits of detection for the capillary electrophoresis instrument for the free 5-
FAM and 6-JOE fluorophores used in our SHAPE experiments were determined by 
analysis of serially diluted free dyes. Dilutions were analyzed until a signal-to-noise ratio of 
3:1 could no longer be maintained (Figure 2.3). For 5-FAM, the detection limit was 20  
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Figure 2.2 Robust, high sensitivity, capillary electrophoresis instrument design. 
Photograph and schematic of the high-sensitivity instrument. The optical cube design 
maximizes light detection and minimizes background noise within each of the three main 
capillary electrophoresis instrument components: excitation, emission and data 
acquisition. 
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zeptomoles (2 × 10-20 mol), or 10,000 molecules. For 6-JOE, the limit was ten-fold higher 
at 200 zmol (2 × 10-19 mol). 
 We then tested the ability of the system to separate, visualize and quantify 
hundreds of fluorescent peaks simultaneously as required in a SHAPE experiment. We 
performed dideoxy sequencing reactions26 using an in vitro transcript corresponding to  
an RNA regulatory signal in the MuLV RNA.25 For this validation experiment, 1 fmol of 
input RNA, or 1,000 times less than that required for a conventional instrument, was used. 
After primer extension, 59 ± 5% of the input RNA was converted to fluorescently labeled 
cDNA, (see Methods). Throughout this work, amounts are reported in terms of the input 
RNA. Triplicate measurements were highly reproducible with standard deviations less than 
5% per nucleotide position (Figure 2.4a). We also compared data from a SHAPE reaction 
on the MuLV RNA obtained with the conventional instrument using 1 pmol RNA versus 
with the high-sensitivity instrument using 1 fmol of the same sample (Figure 2.4b). The two 
electropherograms are highly similar (R = 0.90) (Figure 2.4c). 
We next used the in vitro MuLV transcript to determine the SHAPE limit of 
detection. We probed the structure of this RNA by SHAPE using 1M7,8 and the resulting 
fluorescently labeled cDNA fragments were resolved by both conventional and high-
sensitivity capillary electrophoresis. For a cDNA pool derived from 10 fmol of input RNA, 
we resolved peaks corresponding to all 170 nucleotides in the MuLV RNA using the high-
sensitivity instrument (Figure 2.5a, left). Experiments corresponding to the (+) reagent and 
no-reagent control reactions were resolved in separate capillary electrophoresis runs, 
each also containing the same sequencing marker. These data were combined and 
processed as a single experiment (see Methods) to obtain a SHAPE reactivity profile 
(Figure 2.5b, left) and compared to data from a conventional instrument using 100 times 
more input RNA. The integrated intensities from the high sensitivity instrument correlated 
closely with data from a conventional instrument; the R-value is 0.95 (Figure 2.5c, left).  
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Figure 2.3 Instrument limit of detection. Electropherograms of free 5-FAM (green) and 6-
JOE (yellow) fluorophores shown at their 3:1 signal-to-noise detection limits. Note that the 
x-axis scale is 10-fold larger in the lower panel. 
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Next, we sequentially diluted the SHAPE-produced cDNA library until a 3:1 signal-
to-noise ratio was reached. This occurred at a dilution corresponding to 100 amol input 
RNA (Figure 2.5a and b, right panels). At this level of input RNA, the usable data 
eventually decays to a level below the instrument detection level due to drop-off12,23 
associated with the reverse transcription step (Figure 2.5a, right panel). 
We estimated the amount of cDNA injected into the instrument at the 100 amol 
RNA dilution using electrokinetic injection calculations.27 The quantity injected, Q (in 
moles), onto the capillary electrophoresis instrument is proportional to the sum of 
electrophoretic (µep) and electroosmotic (µeo) velocities of the DNA in the polymer-filled 
capillary 
 Q = (µep + µeo) πr2ECti (1) 
scaled by the capillary area (πr2), the electric field strength (E), the input RNA 
concentration (C) and the injection time (ti). The electro-osmotic mobility is approximately 
zero in this system (data not shown) and cDNA electrophoretic mobility is approximately 
equal to the length of the capillary divided by the separation time, ts (the time between 
cDNA injection and fluorescent primer peak detection),28 thus: 
                                                           Q ≈ (L/Ets) πr2ECti                                                 (2) 
For a solution containing 100 amol input RNA, approximately 1 amol of cDNA was 
physically injected into the instrument [L = 36 cm, E = 217 V/cm, ts = 875 s (measured for 
the primer DNA, and thus a lower limit), C = 10 pM (100 amol / 10 µL) and ti = 30 s]. Given 
that 20 zmol of cDNA are required to visualize a single peak (nucleotide) in the 
electropherogram, 3.4 amol (170 nucleotides 
! 
"  20 zmol) represents the minimal sample 
quantity sufficient to report a SHAPE experiment for the MuLV packaging domain.  
Thus, at 1 amol of cDNA injected onto the instrument, roughly one-third too few 
molecules are present to fully represent the entire SHAPE profile. Consistent with this  
 27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Precision and accuracy of high-sensitivity CE. (a) Mean and standard 
deviations for three dideoxy GTP (ddGTP) sequencing reactions. Error bars are given for 
every data point. Standard deviations were less than 5% of measured intensities 
throughout the trace. (b) Electropherograms for SHAPE reactions performed on the MuLV 
monomer using 5 mm 1M7 and detected using either conventional CE at 1 pmol RNA 
(blue) or high-sensitivity CE at 1 fmol input RNA (red). (c) Correlation of  conventional and 
ultra-sensitive custom CE. 
 
 
 
B
a
b
Elution time  (s)
F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
Elution time (s)
F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
1 pmol / conventional ce
1 fmol / ultrasensitive ce
3 trials ddGTP sequencing / custom ce
5'
5'
c
0.0
1.0
2.0
3.0
4.0
5.0
0.0 1.0 2.0 3.0 4.0 5.0
Fluorescence Intensity 
custom ce (x105 r.f.u)
F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
c
o
n
v
e
n
ti
o
n
a
l 
 C
E
 (
x
1
0
5
 r
.f
.u
) 
R = 0.9
 28 
calculation for the 100 amol SHAPE limit of detection, ~60 nucleotides of SHAPE data in 
the electropherogram integrate to zero or near-zero values, reflecting signal decay that 
results from imperfect processivity of the reverse transcriptase enzyme used to generate 
the cDNA pool and a two-fold reduction in injection efficiency for the longest cDNAs 
(Figure 2.5a and b, right panels, gray bar). These positions also exhibit an accumulation of 
zero magnitude points along the x-axis in a correlation plot (Figure 2.5c, right). Strikingly, 
at this SHAPE limit of detection, the data are nevertheless still highly correlated with data 
obtained using conventional instrumentation at 1 pmol RNA (R = 0.89). Ultra-sensitive 
SHAPE thus yields accurate RNA structural information up to, and even beyond, the limit 
of fluorophore detection. 
2.5 Accurate, nucleotide-resolution secondary structure prediction by ultra-
sensitive SHAPE. 
 SHAPE reactivities are inversely correlated with the probability that a nucleotide is 
base paired, and it is therefore possible to use SHAPE information to predict RNA 
secondary structures accurately.29,30 We used the nucleotide-resolution SHAPE data 
obtained at 10 fmol and 100 amol, equal to 100- and 10,000 fold lower concentrations than 
measurable using conventional instrumentation, to direct RNA secondary structure 
predictions for the MuLV packaging domain. This 170-nucleotide RNA corresponds to a 
regulatory domain at the 5' end of the MuLV RNA genome31 that links two viral genome 
strands into a dimeric structure and comprises the "packaging signal" responsible for 
directing the full genome into nascent viral particles.32 Point mutations in this domain can 
reduce packaging to non-specific levels.25 The MuLV regulatory domain has been 
extensively characterized both structurally and biologically and forms a well-defined 
monomeric structure in the absence of magnesium ion. 
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Figure 2.5 SHAPE limit of detection using MuLV. (a) Processed electropherograms and 
(b) quantitative SHAPE reactivities for MuLV RNA treated with 5 mM 1M7 are shown for 
cDNA pools corresponding to 10 fmol and 100 amol of input RNA. Regions labeled in gray 
in the 100 amol experiment represent data that fall below the statistical detection limit at 
the end of the electropherogram due to signal decay during primer extension.11,12 (c) 
Correlation between SHAPE reactivities, measured at 10 fmol and 100 amol of input RNA, 
with an identical experiment resolved by conventional capillary electrophoresis 
instrumentation at 1 pmol of input RNA.  The full datasets span a range from 0 to ~2 but 
only data to 1.0 are shown to emphasize the strong best-fit correlation for the most 
information-rich measurements.  R-values for the full data range are higher, at 0.95 and 
0.89, respectively. 
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The lowest free energy structures for the MuLV packaging domain were calculated 
using either thermodynamic nearest-neighbor constraints alone or thermodynamic 
nearest-neighbor constraints and SHAPE reactivity data included as pseudo-free energy 
constraints.29 Structure predictions were evaluated by their sensitivity (the percent 
correctly predicted base pairs) and positive predictive value (PPV, the percentage of 
predicted pairs that are present in the accepted structure). In the absence of SHAPE data, 
the secondary structure of the MuLV RNA was predicted with sensitivity and PPV values 
of 36% and 35%, respectively. There were significant errors relative to the accepted 
structure,14 as shown in Figure 2.6a. We then predicted the structure using SHAPE data 
as pseudo-free energy change constraints.29,33 The resulting base pair sensitivities were 
100 and 90%, respectively, and no incorrect base pairs were proposed (PPV = 100%) 
(Figure 2.6b and 2.6c). Consistent with the strong correlation observed between the ultra-
sensitive SHAPE data and data obtained by using pmol RNA amounts, ultra-sensitive 
SHAPE yielded accurate secondary structure predictions with as few as 100 amol, or 
10,000 molecules, of RNA. 
2.6 Ultra-sensitive SHAPE analysis of authentic XMRV. 
We then analyzed a 184-nucleotide region near the 5' end of the XMRV RNA 
genome that is sequentially homologous to the MuLV dimerization and packaging 
regulatory domain. SHAPE reactivity measurements were obtained using 50 fmol aliquots 
of XMRV genomic RNA that had been gently extracted from virions purified from cell 
culture,34 using the 22RV1 virus-producing cell line.35 Integrated SHAPE reactivities 
(Figure 2.7a), taken together with comparison to prior structural analysis of MuLV, were 
used to develop a model for the structure of this regulatory domain. SHAPE probing data 
of RNA isolated from virions indicated clearly that the XMRV genome was present as a 
dimer in mature viral particles. The overall architecture is similar to that of MuLV and 
includes four key dimer interaction elements. Two palindromic sequences, termed PAL1  
 31 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 SHAPE-directed folding of the MuLV genomic RNA monomer. (a) Secondary 
structure of the MuLV monomer in the packaging domain as predicted using 
thermodynamic constraints alone. Missed base pairs and incorrectly predicted base pairs 
relative to the accepted structure14 are denoted by green lines and red x’s, respectively. (b 
and c) MuLV monomer structures predicted using SHAPE constraints to direct RNA 
secondary structure predictions. SHAPE data were obtained at (b) 10 fmol input RNA and 
(c) 100 amol input RNA. 
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and PAL2, form intermolecular duplexes in the dimeric structure, as evidenced by their 
uniformly low SHAPE reactivities (Figure 2.7b). In contrast, when these structures are 
forced into a monomeric conformation, the lowest free energy models contain several 
structures with reactivities that are incompatible with the SHAPE data (Figure 2.8). The 
apical loops in SL1 and SL2 form intermolecular loop-loop kissing interactions, as these 
nucleotides are unreactive towards SHAPE and by analogy with previous work on MuLV 
(Figure 2.6b).23 
We next analyzed the structure of the XMRV genome inside viral particles, again 
using fmol quantities of RNA. Intact viral particles were treated with the 1M7 SHAPE 
reagent, the modified RNA was extracted from the virions and primer extension products 
were quantified by ultra-sensitive SHAPE. Because SHAPE data are highly reproducible, 
the net effect of different environments – including a complex in virio environment – can be 
readily characterized by subtracting one SHAPE profile from another to yield a difference 
plot (Figure 2.7c). The difference analysis revealed three major regions that were less 
reactive, or protected, in virions than in the gently extracted genomic RNA and one 
segment that was more reactive in virions (in blue, Figure 2.7c). These experiments, 
performed on fmol amounts of a structurally uncharacterized authentic retrovirus, provided 
strong clues as to the mechanism of genome packaging in XMRV. 
2.7 Discussion 
2.7.1 Authentic RNAs are difficult to study. 
Most biologically important RNAs are present at very low levels. As a result, 
studies on these RNAs have been limited to indirect functional studies or direct 
experimental studies using in vitro transcribed RNA as models. Recent work blending 
SHAPE with next-generation sequencing has lowered detection limits to the tenth-
picomole (10-13) level.7 Analysis of scarce RNAs might be further optimized by RT-PCR 
approaches but care must be taken so that processing steps do not reduce the  
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Figure 2.7 Structure analysis of authentic XMRV genomic RNA. (a) Integrated SHAPE 
data. (b) Secondary structure model for the XMRV RNA genome. (c) SHAPE reactivity 
differences between the RNA gently extracted from virions versus the genomic RNA 
modified inside virion particles. 
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quantitative accuracy of the resulting structural information.36 In this study, we increased 
the molecular sensitivity of the SHAPE nucleotide-resolution RNA structure probing 
technology to sub-femtomole (10-16) levels by implementing multiple innovations to 
achieve highly sensitive capillary electrophoresis detection of the fluorescently labeled 
cDNA primer extension products. 
2.7.2  Biological implications of US-SHAPE. 
Using ultra-sensitive SHAPE, we examined the structure of the dimerization and 
packaging regulatory domain of XMRV genomic RNA gently extracted from virions and 
also within virions. The ultra-sensitive SHAPE data obtained on authentic viral RNA 
strongly support a model in which XMRV is present as a dimer in mature virions (compare 
Figures 2.7b and Figure 2.8). Genomic dimerization is mediated by four key intermolecular 
interactions at PAL1, PAL2, SL1 and SL2 sequences (Figure 2.7b). Remarkably, even 
though there are extensive sequence differences and nucleotide insertions in XMRV 
relative to MuLV (Figure 2.9), the structures of their respective packaging domains are 
conserved. It is likely that a similar dimeric architecture is evolutionarily conserved among 
all gammaretroviruses. 
The dimerization and packaging domain in the MuLV virus has been intensively 
studied and packaging of the RNA genome involves, in part, a binding interaction between 
the nucleocapsid (NC) domain of Gag and a specific sequence of nucleotides in the 
RNA.37 The MuLV NC protein binds tandem repeats of the sequence UCUG. The 
strongest interactions occur at the first U and final G of the motif and this single-stranded 
element must be flanked by helical regions for highest-affinity binding.25 There are two 
such elements in the MuLV RNA genome and these elements constitute the RNA 
packaging signal for this virus.25 
In contrast, inspection of the SHAPE reactivity differences in the XMRV packaging 
domain for the ex virio and in virio RNA revealed three strong sets of  
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Figure 2.8 XMRV SHAPE data forced into a monomeric conformation. Regions of 
disagreement with the SHAPE data are boxed. 
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protections. By analogy with previous work on MuLV25, virion-specific protection from 
SHAPE reactivity is likely due to protein binding. Virion-specific increases in reactivity are 
most directly attributed to RNA conformational changes. Two of these three motifs are 
unique to XMRV as compared to MuLV.  The first unique motif (Figure 2.7c, motif a) has 
the sequence UCUGUCUUUG and is positioned between the structured elements PAL1 
and SL0 (see boxed nucleotides 238-247, Figure 2.7b). The second motif, 
UCUGAAUCUG, has no analog in MuLV (Figure 2.7c, motif b) and is partially occluded by 
the SL0 helix in the deproteinized RNA structural model (Figure 2.7b, nucleotides 289-
298). Difference plot analysis suggested that the base of helix SL0 is disrupted upon NC 
binding and has a different conformation inside the virion. (Figure 2.7c, region d). This 
model is supported by in virio differences within SL0 compared with the ex virio state 
(Figure 2.10, double-headed arrow). It is also consistent with the known nucleic acid 
chaperone properties of NC.38 The third motif in (Figure 2.7c, motif c), UCUGUAUCUG, is 
identical in both position and sequence to that in MuLV (Figure 2.7b, nucleotides 318-327). 
These three flexible regions in XMRV, consisting of some form of the sequence 
UCUGRRURUG (Figure 2.10, see regions a, b and c), are flanked by structured regions 
and interact most strongly with NC at the first U and last G nucleotides within these motifs 
(capitalized in Figure 2.10, lower panel). 
In conclusion, ultra-sensitive SHAPE has made possible structural analysis of a 
rare, recently discovered, authentic genomic viral RNA. SHAPE characterization of the 
XMRV RNA within virion particles revealed functional determinants of a structure critical 
for packaging. XMRV appears to use a genome packaging strategy that is similar to that 
employed by MuLV, but has distinct and more complex features (Figure 2.10). We 
anticipate that by making analysis of femtomole quantities of RNA possible, high sensitivity 
SHAPE technologies will accelerate functional and structural characterization  
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Figure 2.9 Comparison of XMRV and MuLV packaging domain sequences. Sequence and 
secondary structure model of the XMRV packaging domain. The second strand is shown 
in gray for clarity. Nucleotides that differ in MuLV compared to XMRV are in green; 
deletions relative to MuLV are shown as green triangles. Although there are numerous 
insertions and deletions in XMRV compared to MuLV, the architecture of the packaging 
domains are the same. 
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of many low abundance RNAs, including viral genomes, rare biological mutants, and, with 
further refinement, complex mixtures like messenger RNAs and clinical samples. 
2.8 Experimental Procedures. 
2.8.1 Instrument design and construction. 
 The high-sensitivity capillary electrophoresis laser-induced fluorescence instrument 
is of custom design and construction (see Figure 2.11).39 The detector utilizes a right-
angle excitation design (Figure 2.2). A single-mode fiber-optic cable with an integrated 
lens (3.5-cm focal length, Oz optics) was used to focus the beam from a multiline argon 
laser (488 and 514 nm, JDS Uniphase) into the lumen of a capillary. Light from the 
capillary was collected using a microscope objective (40x, 0.75 na, Plan Fluor, Nikon). The 
laser and capillary were positioned with respect to each other using an XYZ stage 
(Newport). A dichroic filter (FF550-Di01-25X36, Semrock) was used to divide the collected 
light into the 5-FAM and 6-Joe wavelengths. Collection lenses (two collimators for single-
mode fiber/ HPUCO-23-400/700-M-50AC-30OD, Oz Optics) were used to direct the light 
into multimode optical cables (200/230 µm multimode IRVIS fiber/ QMMJ-33-IRVIS-
200/230-3-1, Oz Optics). The entry-way into the fiber optic cable also acted as a pin hole 
to spatially filter the light and remove residual scattered excitation light. Bandpass filters 
(525 and 565 nm; FF01-525/20-25, FF01-565/24-25, Semrock) appropriate for each 
fluorophore were used to further remove excitation light prior to entry into the detector. The 
light was detected, amplified and converted to current using a photomultiplier tube (PMT, 
H7732, Hamamatsu) mounted in a custom housing with shutters and filter slots. Current 
from the PMT was amplified and converted to voltage using a preamplifier (Advanced 
Research Instruments). The signal was then digitized using an analog to digital board 
(National Instruments) and the  
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Figure 2.10 Model for XMRV retroviral genome packaging. Secondary structure model for 
the NC domain of Gag bound to the XMRV packaging signal RNA. Regions with the 
largest changes in SHAPE reactivity for the RNA analyzed inside virions, relative to the ex 
virio RNA, are identified (a-d, bottom panel) with the same labels used in Figure 2.7c. 
Conserved helical elements that stabilize the dimer state and do not differ in conformation 
when in virio and ex virio data are compared are shown schematically as cylinders; these 
helices flank single-stranded regions bound by NC and are components of the protein 
binding site.25 
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instrument was controlled via a custom Labview program designed in conjunction with the 
UNC Chemistry department electronics shop (available upon request). Prefabricated 310 
Genetic Analyzer capillaries 47 cm in length with a 50-µm inner diameter (Applied 
Biosystems) were constructed to have an optical window 36 cm from the inlet. Two 
nonconductive columns were mounted on either side of the optical unit to accommodate 
the capillary inlet, outlet, and custom-built capillary washing system. The capillary 
electrophoresis system was powered by a high voltage power supply (Spellman). A full set 
of mechanical drawings is available upon request.  
2.8.2 Instrument limit of detection. 
 Experiments to determine instrumental detection limits were performed using free 
5-FAM and 6-JOE fluorophores. Samples, diluted from a 10 µM stock, were 
hydrodynamically injected into the system by elevating the capillary at the sample inlet by 
10 cm for 12 s to permit sample introduction via siphoning. The volume of sample injected 
at 0.17 nL/sec27 into the 50-µm capillary using gravity injection was thus approximately 2 
nL. Experiments were carried out in triplicate (Figure  2.4). The capillary was filled with 100 
mM borate (pH 8) and samples were separated at 6 kV for 10 min. Samples were diluted 
until an integrated fluorescence signal-to-noise ratio of 3:1 was no longer maintained. The 
signal-to-noise ratio was calculated by dividing the integrated fluorescence by standard 
deviation of background signal from the first 100 s after injection.  
2.8.3 Retroviral RNA transcripts. 
 The in vitro MuLV RNA construct is 331 nucleotides and spans the dimerization 
and packaging regulatory domain (~170 nts) including 5' and 3' flanking sequences of 46  
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Figure 2.11 Ultra-sensitivity CE and key instrument components. Image of the instrument 
with major components labeled. 
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and 115 nucleotides, respectively.14,17,24 The transcript was generated and purified as 
described.25 
2.8.4 Isolation of XMRV. 
 XMRV was obtained from the constitutively producing XMRV cell line, 22Rv1 
(ATCC),35 cultured in RPMI media with 10% (vol/vol) fetal bovine serum.  Culture fluids 
were collected and filtered, first through 1-µm then 0.45-µm filters, before virus was 
isolated by continuous-flow ultracentrifugation.34 Virus was subtilisin-treated as described40 
and collected by centrifugation through a 3.6-mL 20% (wt/vol) sucrose (in PBS without 
Ca2+ or Mg2+) cushion at 390,000 × g for 2 h at 4 °C. The supernatant was removed, the 
viral pellet was overlaid with ice-cold PBS (without Ca2+ or Mg2+) and the sample was 
centrifuged for an additional 1 hr at 4 °C. The supernatant was aspirated and the pellets 
were resuspended in 600 µL HNS buffer [50 mM HEPES (pH 8.0), 200 mM NaCl, 0.1 mM 
EDTA, 10% (v/v)] for further manipulations, described below. 
2.8.5 SHAPE analysis. 
 XMRV RNA, gently extracted from XMRV virions as described previously,15 was 
incubated in 1× folding buffer [50 mM HEPES (pH 7.5), 200 mM potassium acetate (pH 
7.5), and 5 mM MgCl2] at 37 °C for 20 min prior to modification. The resuspended virus in 
HNS buffer (300 µL) was pipetted into 33.3 µL 50 mM 1M7 (1-methyl-7-nitroisatoic 
anhydride) in DMSO (plus reagent) or neat DMSO (minus reagent), mixed by pipetting and 
incubated at 37 °C for 15 min to modify RNA. Virions were collected by ultracentrifugation 
as described.40 Virion resuspensions were preincubated at 37 °C for 5 min and 300 µL of 
virus solution was pipetted into 33 µL solutions of either 1M7 (50 mM) or DMSO at 37 °C. 
Solutions were mixed by pipetting and incubated for 15 min at 37 °C. Samples turn from 
faint yellow to dark orange upon reaction with 1M7.  Samples were resuspended in 100 µL 
of 1× lysis buffer [50 mM Hepes (pH 7.5), 200 mM NaCl, 3 mM MgCl2] and lysed with 1% 
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(wt/vol) SDS and 20 mg/mL proteinase K at 22 °C for 30 min. The lysate was extracted 
four times with phenol/chloroform/isoamyl alcohol (25:24:1), followed by four extractions 
with pure chloroform. Samples were then precipitated with ethanol and stored in 70% 
ethanol at -20 °C until primer extension. 
  In vitro generated MuLV RNA monomer transcripts (2 pmol) were renatured by 
heating at 95 °C for 3 min in 12 µL water, cooled on ice for 3 min and equilibrated at 37 °C 
for 3 min in a folding buffer without magnesium [50 mM HEPES (pH 7.5), 200 mM 
potassium acetate (pH 7.5)]. SHAPE modification was performed by treating 9 µL MuLV 
RNA with 1 µL 1M7 (50 mM in DMSO), followed by incubation at 37 °C for 2 min. RNA 
was recovered using a precipitation approach optimized for the quantitative recovery of 
low abundance RNAs [2.5 vol ethanol, 1 vol isopropanol, 1 µL glycogen (20 mg/mL); 
incubation at -20 °C for 60 min; and centrifugation at 20,000× g]. Pellets were 
resuspended in 6 µL 1/2× TE [5 mM Tris, 0.5 mM EDTA (pH 8.0)] buffer.  
2.8.6 Primer extension. 
 The protocol was described in detail previously.4,14 DNA primers incorporated 
locked nucleic acid nucleotides (LNA, underlined) for use on low-copy RNA to increase 
binding affinity and stringency.41-43 The efficiency of primer extension using LNA-
containing primers was calculated to be 59 ± 5% based on the fraction full-length 
extension product relative to the sum of this value and one-half the unextended primer 
peak (to correct for a 2:1 primer to RNA molar ratio during primer extension), using an 
electropherogram from a no-reagent control reaction. MuLV primers (5'-GGUGC ACCAA 
AGAGU CCAAA AGC-3', 5'-end labeled with 5-FAM or 6-JOE) annealed 3' of the MuLV 
dimerization domain (nucleotides 422 to 445) XMRV primers (5'-GAAGT CTCTG TCTCT 
CGTCC CCC-3') annealed to nucleotides 443 to 468 in the genome sequence. Primers 
(0.5 µL; 2 fmol) were annealed to XMRV RNA (6 µL; 1 fmol in 1/2× TE buffer) by heating 
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at 65 °C and 45 °C for 5 min and then snap-cooled on ice. Reverse transcription buffer [3 
µl; 200 mM Tris (pH 8.0), 250 mM KCl, 10 mM MgCl2, 2 mM each dNTP, 20 mM DTT] was 
added at 0 °C, and primer extension was performed with Superscript III (Invitrogen) 
reverse transcriptase (0.5 µl; 100 U) at 45 °C for 1 min, followed by incubation at 52 °C 
and 65 °C, for 10 min each. MuLV transcript RNA was subjected to primer extension 
exactly as described above except that primer and RNA concentrations were 2 and 1 
pmol, respectively. Reactions were quenched by cooling to 4 °C and addition of 3 M 
sodium acetate (pH 5.2). A sequencing marker was generated by adding 0.5 µL dideoxy-
GTP (10 mM) to the primer extension reaction mixture using unmodified RNA. The 1M7 
and DMSO reaction mixes were each combined with equal amounts of dideoxy-GTP-
terminated sequencing ladders, precipitated with ethanol, and resuspended in deionized 
formamide (20 µl).  
2.8.7 Capillary electrophoresis. 
 For conventional capillary electrophoresis, cDNA fragments were resolved on an 
Applied Biosystems 3130 instrument. This instrument is fully automated for use with high 
abundance cDNA samples of 1 pmol or greater. The samples were loaded onto microtiter 
plates and injected onto the instrument using standard instrument protocols. MuLV and 
XMRV cDNA fragments, ranging in concentration from 100 amol to 50 fmol of input RNA, 
were resolved by custom high-sensitivity capillary electrophoresis.  For ultra-sensitive 
SHAPE, samples of 1 to 10 µL were electrokinetically injected (10.2 kV for 30 s) onto a 47 
cm (50-µm inner diameter) uncoated capillary containing Pop7 (Applied Biosystems) as 
the internal polymer. The detection window was placed at 36 cm. Voltage was applied 
using positive polarity (10.2 kV for 60 min) and immersing the capillary ends in a 1× 
running buffer (Applied Biosystems). The PMT voltages were 0.9 kV and the laser power 
was 2 mW. Excitation was achieved using an argon laser at 488 and 514 nm wavelengths 
focused within the capillary at the detection window. 5-FAM was used to detect cDNAs 
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corresponding to SHAPE structure probing and the lower sensitivity dye, 6-JOE, was used 
for sequencing. A single high-sensitivity SHAPE experiment was thus resolved in two 
separate capillary electrophoresis runs, one each for the plus- and no-reagent reactions.  
Sensitivity for sequencing is not a critical issue because sequencing can be performed 
with an in vitro transcript or with DNA rather than a scarce biological sample. 
2.8.8 Data processing and structure prediction. 
 Raw sequence traces were corrected for dye variation and signal decay; peak 
intensities were integrated using ShapeFinder.12 Traces were analyzed by combining data 
from two separate capillary runs. Each capillary electrophoresis separation contained (i) a 
reaction performed in the presence or absence of 1M7 (detected using a FAM-labeled 
primer) and (ii) a sequencing reaction (labeled with JOE) performed using dideoxy GTP. 
Data from the two runs were aligned using the identical sequencing lanes and then 
analyzed as described.12 SHAPE reactivities were normalized by dividing by the average 
intensity of the 10% most reactive nucleotides, after excluding outliers found by box plot 
analysis.29 SHAPE reactivity information was used to impose a pseudo-free energy 
change constraint in conjunction with nearest neighbor thermodynamic parameters in the 
prediction program RNAstructure.29,30,33 
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CHAPTER 3 
 
IMMATURE MULV GENOMIC RNA PACKAGED AS A STABLE INTERMEDIATE 
STRUCTURE 
 
3.1 Retroviral genomic RNA is packaged in an immature state.   
 During viral replication, a structurally distinct genomic RNA dimer is packaged into 
immature nascent virions.1,2 As only mature virus has been found to be infective, RNA 
structural changes have been proposed to be an important part of maturation3,4 and 
subsequent pathogenesis. The RNA structure of immature MuLV has not been 
characterized and only bulk measurements of global structure4 are currently available to 
provide information to help distinguish between immature and mature MuLV particles. 
Likewise, there is no information available to determine whether RNA structures detected in 
vitro are in the immature or mature dimeric state. Presumably, in light of the short life-span 
of the immature state, current RNA structures of MuLV are of the mature dimer. 
Furthermore, the packaged state of MuLV genomic RNA has not been analyzed. This 
limitation is based largely on the extraordinary difficulty of producing enough RNA to perform 
structural analysis using traditional techniques.  Considering the tight link between viral 
structure and function, the inability to analyze these structural states presents a 
considerable barrier to fully understanding viral pathogenesis.  Here I use new technology 
on MuLV RNA to try to address this formerly intractable problem. 
3.2 Ultra-sensitive SHAPE for highly sensitive structural analysis. 
 Selective 2'-Hydroxyl Acylation analyzed by Primer Extension (SHAPE) allows 
characterization of RNA structure at single nucleotide resolution.5-8 In a traditional SHAPE 
experiment, target RNA is first equilibrated with a physiologically-relevant folding solution9 
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(e.g., 50 mM HEPES, 200 mM KOAc, 5 mM MgCl2). When added to RNA, 1-methyl-
nitroisatoic anhydride (1M7),10 or other SHAPE reagents,9,11 react with flexible (single-
stranded) nucleotides to form a bulky RNA adduct. Adduct locations are then mapped as 
stops in a subsequent primer extension reaction using fluorescently labeled primers.12 
Structure-specific cDNAs are separated by capillary electrophoresis and the resulting 
electropherogram is processed to yield a reactivity profile detailing the likelihood of base 
pairing for every RNA nucleotide (Figure 3.1a). SHAPE has been successful in analyzing 
many important retroviral RNA structures, including the entire HIV-1 genome6 and the 
mature Moloney Murine Leukemia virus (MuLV) dimerization and regulatory domain.13 
However, structural analysis of authentic viral RNA has remained problematic as purification 
from infected cells and virions typically yields only attomoles to femtomoles (10-18 to 10-15) of 
material, and capillary electrophoresis-based structural technologies, like SHAPE, require 
picomoles of RNA.5  
 I have improved the detection limits of capillary electrophoresis (CE) based-
techniques by four orders of magnitude directly by designing and building a custom CE 
instrument with sub-femtomole SHAPE sensitivity.14 I now apply this technology, ultra-
sensitive SHAPE (US-SHAPE), to analysis of the secondary structure of the dimerization 
and packaging domain of the Moloney murine leukemia virus (MuLV), using samples 
assayed with SHAPE reagents both after extraction from and while within immature 
retrovirus particles.  I find that this important regulatory domain has a unique structure while 
it remains an immature, non-infectious particle. From this high-resolution structural 
information, we created a series of mutants in authentic viruses designed to mimic the 
immature state and test our structural model. We discovered a mutant which is at least 10-
fold deficient in replicative fitness. I then devised a structural model of the packaged 
immature genomic RNA that is functionally relevant as determined by mutation studies. 
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Figure 3.1 Structure analysis of authentic MuLV immature genomic RNA as a dimer. (a) 
Integrated SHAPE data. (b) Secondary structure model for the immature MuLV RNA 
genome. (c) Protection factor calculated by normalized SHAPE reactivity differences 
between the RNA gently extracted from virions versus the genomic RNA modified inside 
virion particles. (d) Secondary structure model for the mature MuLV palindromic 2 (PAL2) 
sequence in an intermolecular duplex. 
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3.3 US-SHAPE analysis of ex virio immature MuLV authentic RNA. 
 Immature MuLV RNA used here is created by transfection of a well-known protease 
mutant that produces an inactive protease that prevents Gag polyprotein cleavage, and thus 
viral maturation (see methods).1,3,15,16 In the laboratory, the result of a large-scale, 
specialized preparation of transfected cells is only a few hundred femtomoles because 
protease deficient virus is only capable of a single round of replication. I utilized US-SHAPE, 
developed precisely for the structural analysis of low-copy number authentic RNAs, to 
analyze the MuLV dimerization and packaging regulatory domain.17,18 This region, spanning 
170 nucleotides, was selected because it is the most prominent interaction site between the 
two genomic strands. SHAPE reactivity measurements were obtained using 50 fmol aliquots 
of MuLV genomic RNA that had been gently extracted from virions purified from cell culture. 
Processed SHAPE reactivities (Figure 3.1a) were used to develop a model for the structure 
of this regulatory domain and compared to previously determined structural models of this 
domain in the mature state.13,19 SHAPE probing data of RNA isolated from immature virions 
display a similar overall architecture to that of mature MuLV RNA13 with one major 
exception; the structural model of the dimerization and packaging regulatory domain 
contains only three key dimerization elements (PAL1, SL1. and SL2) whereas the mature 
dimer state contains four such interaction elements (PAL1, PAL2, SL1, and SL2). The apical 
loops in SL1 and SL2 form intermolecular loop-loop kissing interactions in both the immature 
and mature state, as these nucleotides are unreactive towards SHAPE and are analogous 
with previous observations in MuLV (Figure 3.1b, SL1 and SL2).20 A palindromic sequence, 
termed PAL1, forms a 10 base-pair intermolecular duplex in both dimeric structures, as 
evidenced by their uniformly low SHAPE reactivities (Figure 3.1b, PAL1). A second 
palindromic sequence, PAL2, forms an intramolecular stemloop in RNA extracted from 
immature virus (Figure 3.1b, nucleotides 283 through 298), while this sequence forms an 
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intermolecular duplex in the mature ex virio dimer extracted from mature particles (Figure 
3.1d).  
3.4 US-SHAPE analysis of in virio immature MuLV RNA. 
 I next analyzed the structure of the MuLV genomic dimer within immature viruses, 
again using femtomolar quantities of RNA as described.13,14 Intact viral particles were 
treated with 1M7 SHAPE reagent, the modified RNA was extracted, and the primer 
extension products were quantified. Highly reproducible SHAPE profiles from the ex and in 
virio RNAs were used to create differential plots to reveal the net effect of complexation in 
the in virio environment. For example, protein binding sites, indicated by a decrease in 
SHAPE reactivity in the in virio modified RNA relative to the ex virio modified RNA, are 
readily detected using a protection factor plot. Protection factor analysis was done by 
subtracting the in virio from the ex virio SHAPE profile and dividing the difference by the in 
virio profile. This analysis revealed two major regions (blue in Figure 3.1c) that are protected 
within the virus particle. The protections (Figure 3.1c, labeled NC) are consistent with known 
nucleocapsid (NC) binding sites for MuLV (Figure 3.1b, boxed).19 Taken together, I conclude 
that the genomic RNA dimer is bound to the NC domain of Gag protein within immature 
virions, but the immature dimer, containing an unformed PAL2 duplex, is structurally distinct 
from the mature state. 
3.5 Immature MuLV RNA resembles a late kinetic step in genomic dimerization. 
 In recent work from our lab, I used time-resolved SHAPE to develop a single 
nucleotide resolution mechanistic model for dimerization of an in vitro MuLV RNA genome.21 
The culmination of this work was a structural “movie” of genomic RNA dimerization in the 
presence and absence of nucleocapsid (NC) protein. Here, I extend our analysis to consider 
the immature MuLV structural state by comparing the SHAPE reactivity profiles of immature 
MuLV RNA and profiles taken during the dimerization pathway.  Strikingly, I found that the 
immature RNA structure closely resembles a late kinetic step in the dimerization of the 
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genome (Figure 3.2a), with a linear correlation coefficient of 0.84 (Figure 3.2b).  If I correlate 
the immature structure to each of the 16 consecutive structural “snapshots” taken during 
dimerization I find that the structure correlates to a single step late in the monomer to dimer 
transition (Figure 3.2c). I conclude that the immature state is an intermediate in the 
dimerization of MuLV genomic RNA. 
3.6 Mutation and replicative fitness of authentic immature genomic RNA. 
 I next set out to validate our secondary structural model of the dimerization domain 
by creating a series of mutations intended to mimic the secondary structure of MuLV RNA in 
the immature state. Mutants were designed with two structural goals: first we incorporated 
one or more mutations within the PAL2 sequence that intended to affect the formation of the 
PAL2 intermolecular duplex and second, I devised mutations to allow or disrupt 
nucleocapsid binding (Figure 3.3a).  
 The resulting MuLV PAL2 variants were transfected into live viruses and allowed to 
replicate in a sarcoma positive leukemia negative (S+L-) focus assay (see methods).22 The 
focus inducing units are counted five days after transfection and their resulting replication 
efficiencies, normalized to the native sequence, are determined (Figure 3.3b). Mutations 
were made that should strengthen, completely delete, or completely disrupt the PAL2 
intermolecular duplex seen in the immature state.  Increasing the G-C base-pair content of 
the PAL2 stemloop was used to strengthen the PAL2 stemloop and these constructs 
resulted in a viable virus still capable of replication with similar efficiency to the native 
sequence (70 +/- 40%) (Figure 3.3b, mutated). Surprisingly, the deletion variant (Figure 
3.3b, deleted), with a completely excised PAL2 region (nucleotides 283 - 298), also 
replicated with an efficiency (70 +/- 20%) similar to the native sequence (Figure 3.3b, 
native). In contrast, one mutant construct wherein the PAL2 sequence was replaced with a 
string of A’s (Figure 3.3a and b, all to A’s) was reproducibly found to be replication deficient 
(10 +/- 10%) as compared to the native sequence. In summary, we found that while neither 
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strengthening nor complete deletion of PAL2 was capable of preventing the infectivity of the 
MuLV retrovirus complete disruption of secondary structure of PAL2 produced a 
reproducible 10-fold replication deficiency.  This is likely because it forced altered spacing 
between NC binding motifs; these date provide clues to the function of the RNA in the 
immature state. 
3.7 Discussion 
3.7.1 US-SHAPE for authentic immature RNA structure. 
 Retroviral RNA genomes form myriad structures that are governed by critical 
interactions with either the nucleocapsid protein or the nucleocapsid domain of Gag 
polyprotein.15,23,24 I have made use of a powerful new method based on SHAPE9 technology 
to explore interactions between NC and the immature RNA genome of the Moloney murine 
leukemia virus (MuLV). In this approach, ultrasensitive SHAPE (US-SHAPE), I used a two-
color capillary electrophoresis instrument with femtomole (10-15) sensitivity for SHAPE 
experiments on authentic viral RNA.14 The high sensitivity of this instrument has allowed me 
to characterize authentic immature RNA genomes within MuLV virions at single-nucleotide 
resolution.  
 Before now only two pieces of empirical evidence were available to distinguish 
between the immature and mature states of the MuLV virus. First, cryo-electron microscopy 
studies of the immature MuLV virion show concentric circles of uncleaved Gag polyprotein 
subunits including matrix, capsid, and nucleocapsid proteins.1 Second, genomic RNA 
extracted from immature virions has a lower thermal stability than their mature 
counterparts,3 suggesting a significant difference in secondary structure. Our results verify 
the packaging and regulatory signal RNA exists in a structurally distinct conformation in the 
immature state and I have created secondary structure models of the RNA within the 
immature state (Figure 3.1b).  
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Figure 3.2 Comparison of immature MuLV RNA SHAPE reactivities with SHAPE reactivities 
of the MuLV dimerization pathway. (a) (Top) Integrated SHAPE data of authentic MuLV 
immature genomic RNA as a dimer. (Bottom) Integrated SHAPE data of a late timepoint in 
the dimerization of MuLV. (b) Correlation of SHAPE data in (a). (c) Correlation of immature 
RNA SHAPE reactivity to every timepoint in the dimerization of MuLV.  
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3.7.2 Immature RNA is bound to NC domain of Gag polyprotein. 
 Our in virio results confirm that the RNA is bound to the NC domain of Gag 
polyprotein while within the immature virion (Figure 3.1c).  This binding interaction occurs 
primarily between the NC domain of Gag and tandem UCUG repeats within the dimerization 
and packaging regulatory domain. One approach to increasing binding affinity is to eliminate 
off-target binding events, and it appears that the viral RNA uses this approach by flanking 
each single-stranded binding domain with helical regions, thus sequestering these sites in 
base-pairing interactions (Figure 3.1b, boxed).19 This is particularly interesting as RNA-
protein interactions have often been found to be non-specific and electrostatic-based, hence 
specificity in this case is derived from the RNA directly.  
3.7.3 Mimicking the immature state. 
 We next attempted to capture the immature state by creating various viral constructs 
with mutated PAL2 regions and analyzing their respective effects within authentic virions. 
We created three MuLV variants (Figure 3.3a) and compared their replication efficiency to 
the native MuLV sequence in an in vivo replication assay (Figure 3.3b). The first mutant 
contained alternative base-pairings in the PAL2 sequence intended to both strengthen this 
intramolecular duplex and mimic the immature form of the virus. This mutation was expected 
to be deficient in replication, however it replicated with near native efficiency (Figure 3.3b, 
mutated). Contrary to several previously published results we found that deletion of the 
entire PAL2 sequence had little effect on viral replication, with near native efficiency being 
observed (Figure 3.3b, deleted). Only disruption of the PAL2 duplex via a mutation that 
changed every residue in the duplex to an adenosine residue caused the virus to exhibit a 
slight deficiency in replication (~10-fold) of its genome (Figure 3.3b, all to A’s), although this 
mutant was still capable of multiple rounds of replication.  
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Figure 3.3 Mutation and replication efficiency of authentic immature genomic RNA. (a) 
Structural model for MuLV genomic RNA. Structured regions are shown as cylinders. Known 
NC binding sites are boxed. Four mutations are shown with different conformations of PAL2 
(dashed box). (b) Replication efficiencies of each of the four PAL2 mutants are shown with 
error bars as calculated from an S+L- focus assay.22 
 
  
0
20
40
60
80
100
R
e
p
li
c
a
ti
o
n
 e
ff
ic
ie
n
c
y
!PAL2
native   mutated     deleted      all to A’s
b
a
P
A
L
1
S
L
1
S
L
2
5‘
5‘
] 3‘
S
L
1
S
L
2
3‘
form of
PAL2
UU CAU GGC UU
226
GU U G CC G UUU
309
S
L
0
form of
PAL2
native           mutated        deleted        all to A’s
]
NC1 NC2
 60 
3.7.4 Defining a precise structural spacing for NC binding to immature RNA. 
 These unexpected results suggested to us that factors other than specific sequence 
identity are the primary determinants of immature viral dimerization.  We hypothesize that a 
precise ‘structural spacing’ of the NC binding sites is required for these RNA-protein 
interactions. Natively, this structural spacing includes two tandem unstructured UCUG motifs 
flanked by highly structured regions. When the structural spacing is fulfilled by flanking 
structured regions, as in the native, mutated, and deleted variants (Figure 3.3a), NC is 
capable of binding and chaperoning the RNA to its mature infectious state (Figure 3.3b). 
However, when the structural spacing between tandem UCUG motifs is changed sufficiently, 
as it was when the entire sequence was change to A’s (Figure 3.3a, all to A’s), the 
packaging prerequisite is not fulfilled, nucleocapsid does not bind, and thus viral replication 
is deficient (Figure 3.3b).  
3.7.5 Biological implications of the immature state. 
 We have conducted a fairly wide range of genomic RNA mutational studies which fail 
to completely disrupt the virus’s ability to replicate, resulting in a general hypothesis that the 
structure of the RNA within the immature virion is not critical to maturation of viral particles. 
In contrast, our current work indicates that a precise structural spacing is critical for NC 
binding and maturation of the retrovirus. In addition, our data suggests that the immature 
RNA secondary structure is a legitimate intermediate in the viral replication pathway as it 
closely resembles a late kinetic step in the dimerization of the MuLV genome. We propose a 
functional model where the immature RNA is packaged as a “kinetically trapped” RNA state 
containing an intramolecular helix that, when bound to the nucleocapsid domain of the 
polymeric Gag protein, is physically constrained by the Matrix protein and embedded in the 
viral membrane (Figure 3.4a). Once Gag polyprotein is cleaved into its three constituent 
proteins the viral genome is released and free NC protein chaperones the genomic RNA into 
its mature infectious form (Figure 3.4b). Both NC domain and free NC binding to genomic 
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RNA is controlled by a precise structural spacing of two tandem unstructured UCUG motifs 
flanked by structural elements. Without this precise structural configuration, NC does not 
properly recognize and chaperone the RNA to its final infectious state. 
3.8 Experimental Procedures. 
3.8.1 Creation of Immature MuLV RNA. 
 Immature MuLV genomic RNA was created using a well-characterized mutant in 
which the active site of the viral protease contains an aspartate to leucine substition (D32L).1 
When the mutated plasmid is transfected into NIH 3T3 mouse cells, an inactive form of the 
viral protease is produced (PR-) which is incapable of cleaving Gag polyprotein. The 
abrogation of Gag prevents maturation and the virion contains immature MuLV genomic 
RNA. After transfection of pMuLV-D32L, infected cells produce virus. MuLV genomic RNA is 
packaged into nascent immature virions along with PR-. Because PR- cannot cleave Gag, 
the virion remains in the immature and non-infectious state. Because immature virus is not 
infectious, only one round of immature virions is produced per transfection. The viral titer is 
therefore in attomoles (~10,000 molecules) and a large-scale prep is required to produce 
femtomole amounts of immature genomic RNA. Immature virions are pelleted by 
centrifugation at 25,000 rpm at 4 °C and resuspended in PBS. The immature RNA is then 
modified within the immature virions by addition of 5 mM 1M7. For both ex virio RNA or after 
in virio modification, the virions are lysed by incubating at 37 °C for 30 minutes in a buffer 
containing Tris pH 7.4, EDTA, SDS. NaCl, proteinase K. Cell lysate is cleared by 
centrifugation and the viral RNA is purified by phenol-chloroform extraction and ethanol 
precipitation. Immature MuLV RNA is then analyzed by US-SHAPE.14 
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Figure 3.4 Model for MuLV retroviral genome packaging. Secondary structure model for the 
(a) NC domain of Gag polyprotein bound to the MuLV packaging signal RNA within the 
immature virion and (b) NC protein bound to the MuLV packaging signal RNA with the 
mature virion. 
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3.8.2 US-SHAPE analysis of immature RNA. 
 MuLV RNA, gently extracted from immature MuLV PR- virions as described 
previously,13 was incubated in 1x folding buffer [50 mM HEPES (pH 7.5), 200 mM potassium 
acetate (pH 7.5), and 5 mM MgCl2] at 37 °C for 20 min prior to modification. The 
resuspended virus in HNS buffer (300 µL) was pipetted into 33.3 µL 50 mM 1M7 (1-methyl-
7-nitroisatoic anhydride) in DMSO (plus reagent) or neat DMSO (minus reagent), mixed by 
pipetting and incubated at 37 °C for 5 min to modify RNA. Virions were collected by 
ultracentrifugation as described.25 Virion resuspensions were preincubated at 37 °C for 5 
min and 300 µL of virus solution was pipetted into 33 µL solutions of either 1M7 (50 mM) or 
DMSO at 37 °C. Solutions were mixed by pipetting and incubated for 15 min at 37 °C. 
Samples turn from faint yellow to dark orange upon reaction with 1M7.  Samples were 
resuspended in 100 µL of 1x lysis buffer [50 mM Hepes (pH 7.5), 200 mM NaCl, 3 mM 
MgCl2] and lysed with 1% (wt/vol) SDS and 20 mg/mL proteinase K at 22 °C for 30 min. The 
lysate was extracted four times with phenol/chloroform/isoamyl alcohol (25:24:1), followed 
by four extractions with pure chloroform. Samples were then precipitated with ethanol and 
stored in 70% ethanol at -20 °C until primer extension. 
 The primer extension protocol was described in detail previously.5,20 DNA primers 
incorporated locked nucleic acid nucleotides (LNA, underlined) for use on low-copy RNA to 
increase binding affinity and stringency.26-28 MuLV primers (5'-GGUGC ACCAA AGAGU 
CCAAA AGC-3', 5'-end labeled with 5-FAM or 6-JOE) annealed 3' of the MuLV dimerization 
domain (nucleotides 422 to 445) Primers (0.5 µL; 2 fmol) were annealed to MuLV RNA (6 
µL; 1 fmol in 1/2x TE buffer) by heating at 65 °C and 45 °C for 5 min and then snap-cooled 
on ice. Reverse transcription buffer [3 µl; 200 mM Tris (pH 8.0), 250 mM KCl, 10 mM MgCl2, 
2 mM each dNTP, 20 mM DTT] was added at 0 °C, and primer extension was performed 
with Superscript III (Invitrogen) reverse transcriptase (0.5 µl; 100 U) at 45 °C for 1 min, 
followed by incubation at 52 °C and 65 °C, for 10 min each. Reactions were cooled to 4 °C 
 64 
and quenched by addition of 3 M sodium acetate (pH 5.2). A sequencing marker was 
generated by adding 0.5 µL dideoxy-GTP (10 mM) to the primer extension reaction mixture 
in a reverse transcription reaction with unmodified RNA. The 1M7 and DMSO reaction mixes 
were each combined with equal amounts of dideoxy-GTP-terminated sequencing ladders, 
precipitated with ethanol, and resuspended in deionized formamide (20 µl). 
 3.8.3 Capillary electrophoresis. 
 MuLV cDNA fragments, extended from 50 fmol of input RNA, were resolved by 
custom high-sensitivity capillary electrophoresis as described.14 For ultra-sensitive SHAPE, 
10 µL samples, in deionized formamide, were electrokinetically injected (10.2 kV for 30 s) 
onto a 47 cm (50-µm inner diameter) uncoated capillary containing Pop7 (Applied 
Biosystems) as the internal polymer. The detection window was placed at 36 cm. Voltage 
was applied using positive polarity (10.2 kV for 60 min) and immersing the capillary ends in 
a 1x running buffer (Applied Biosystems). The PMT voltages were 0.9 kV and the laser 
power was 2 mW. Excitation was achieved using an argon laser at 488 and 514 nm 
wavelengths focused within the capillary at the detection window. 5-FAM was used to detect 
cDNAs corresponding to SHAPE structure probing and the lower sensitivity dye, 6-JOE, was 
used for sequencing. 
3.8.4 Data processing and structure prediction. 
 Raw sequence traces were corrected for dye variation and signal decay; peak 
intensities were integrated using ShapeFinder.29 Traces were analyzed by combining data 
from two separate capillary runs. Each capillary electrophoresis separation contained (i) a 
reaction performed in the presence or absence of 1M7 (detected using a FAM-labeled 
primer) and (ii) a sequencing reaction (labeled with JOE) performed using dideoxy GTP. 
Data from the two runs were aligned using the identical sequencing lanes and then analyzed 
as described29. SHAPE reactivities were normalized by dividing by the average intensity of 
the 10% most reactive nucleotides, after excluding outliers found by box plot analysis.30 
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SHAPE reactivity information was used to impose a pseudo-free energy change constraint 
in conjunction with nearest neighbor thermodynamic parameters in the prediction program 
RNAstructure.30-32 
3.8.5 S+/L- viral replication assay. 
 The assay was performed as described.22 When cultured, sarcoma positive leukemia 
negative (S+/L-) cells cannot release foci of murine sarcoma virus (MSV) unless they are 
superinfected with MLV. After superinfection, focus forming units form in direct proportion to 
the concentration used for superinfection. This assay is thus used as a rapid and sensitive 
technique for the replicative fitness of viral mutants. S+L- cells are plated in 60 mM plastic 
petri dishes using 105 cells per dish. The next day, the S+L- cells are infected with either 
native or mutated MuLV. The foci are counted five days after infection using microscopy. 
The foci appear as lytic areas in the form of grapelike clusters of round cells. Foci were 
normalized to native viral sequence and reported as a percentage with errors calculated by 
triplicate measurements. 
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CHAPTER 4 
A GUANOSINE-CENTRIC MECHANISM FOR RNA CHAPERONE FUNCTION 
 
 
4.1 RNA chaperones.   
RNA molecules function as the central information conduit in biology.1,2 This 
information is encoded both in the primary sequence and in higher order structures involving 
both base pairing and tertiary interactions. Higher order structure is built up from only four 
fundamental building blocks, and both biologically functional and non-functional structures 
are highly stable. On their own, many RNAs fold via apparently complex pathways involving 
multiple, long-lived intermediates in folding landscapes that are characterized as rugged.  
Proteins with RNA chaperone activity dramatically simplify these complex pathways by 
lowering the barriers between RNA states and by facilitating rearrangement of misfolded 
states. An important class of RNA chaperones is those that bind non-specifically and in an 
ATP-Independent way to RNA. Non-specific RNA chaperone proteins accelerate strand 
annealing and exchange reactions, destabilize misfolded states, and facilitate 
interconversions between RNA states. However, the molecular mechanisms for these 
reactions are poorly understood.  In this work, I uncover a remarkably simple mechanism by 
which retroviral NC proteins, an important class of RNA chaperone, facilitates an RNA 
genome conformational isomerization essential for viral replication. 
4.2 The role of RNA chaperones in retroviral biology. 
As is the case with many RNAs, the RNA genomes of many viruses contain dynamic 
higher order structures that are essential for the function of these large RNAs.3 In one 
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example, retroviruses including HIV-1 and the Moloney murine leukemia virus (MuLV) 
obligatorily package two RNA genomes in each virus particle. Packaging is governed, in 
part, by physically linking the two RNA strands via a non-covalent dimer structure involving 
nucleotides near the 5' end of the genome.4-6 Like many processes involving RNA 
conformational changes, dimerization is catalyzed by an RNA chaperone, the nucleocapsid 
domain of the retroviral Gag protein,7 which is copackaged with the viral RNA.8 The isolated 
nucleocapsid (NC) protein, which functions independently in other viral replication steps, 
facilitates dimerization in vitro7 and mutations in NC abrogate viral replication in vivo.9 The 
RNA chaperone activities of the NC proteins are well-established;10,11 however, the 
molecular basis for chaperone function remains unresolved. 
Genome dimerization in MuLV is mediated by base pairing and tertiary interactions 
at a 170 nucleotide RNA domain located in a conserved noncoding region near the 5’ end of 
the genome.12-14 The simplified transcript of the MuLV dimerization domain used here 
functionally recapitulates the genomic dimerization element as it dimerizes under 
physiological-like conditions in vitro,15-17 overlaps with sequences sufficient to mediate 
packaging in vivo,18 and has a structure similar to that of authentic genomic RNA isolated 
from virions.19 Point mutations in this domain eliminate selective packaging.20 
4.3 Initial characterization of genomic RNA dimerization. 
Conformational changes in large RNAs can be characterized in a general way by 
resolving distinct states by non-denaturing gel electrophoresis (Figure 4.1a-d). In the 
presence of magnesium ion and upon incubation at 37 °C, the RNA monomer was 
converted to a dimer at an observed rate (kobs) of 0.15 min–1 (Figure 4.1a). An intermediate 
(I) is also visible (Figure 4.1a, I) In the presence of a saturating concentration of NC, equal 
to ~1 protein per six RNA nucleotides21, dimerization is accelerated ten-fold (kobs= 1.6 min–1) 
and the intermediate is no longer visible (Figure 4.1 e). Thus, as assessed globally, NC  
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Figure 4.1 Visualization of MuLV dimerization by non-denaturing electrophoresis. (a) 
Representative gels are shown for wild type (wt), inosine variant (ITP), wt + 8 µM NC, and 
ITP + 8 µM NC at 600 nM MuLV RNA (b). 1st order exponential curves are shown on a 
logarithmic axis describing each of the rates of dimerization by gel shift.   
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accelerates dimerization and reduced the relative population of at least one intermediate 
state (Figure 4.1a and b). 
4.4 Complex, time-dependent changes in the dimerization domain. 
I developed a nucleotide-resolution model for assembly of the MuLV dimerization 
domain using time-resolved SHAPE (selective 2'-hydroxyl acylation analyzed by primer 
extension).22 Time-resolved SHAPE employs a fast acting reagent, benzoyl cyanide (BzCN),  
that either reacts to form a 2'-O-adduct at conformationally flexible nucleotides or undergoes 
rapid self-inactivation by hydrolysis (0.25s half life).23 The short in-solution lifetime of the 
reagent means that time-resolved SHAPE yields one second, single nucleotide resolution 
snapshots of RNA structure.24 
I initially established models for the structures19,25 of the initial monomer state, 
obtained in the absence of magnesium ion, and the final dimer state reflecting the structure 
of the RNA after a 30 min incubation (Figure 4.2a). SHAPE reactivities and the secondary 
structure models of the monomer and dimer correlate well. For example, nucleotides with 
high SHAPE reactivities are conformationally dynamic,26 and tend to occur in single-
stranded regions of the RNA in both the monomer and dimer states (Figure 4.2a, red 
nucleotides). Conversely, nucleotides with low SHAPE reactivities occur preferentially in 
base-paired structures (Figure 4.2a, in black). These models agree well with prior accepted 
structures for the MuLV dimerization domain,17 including that obtained using authentic 
genomic RNA.19 
Dimerization was initiated by addition of magnesium ion. One second snapshots over 
the course of dimerization were obtained by mixing a portion of the evolving reaction with an 
aliquot of the reagent, BzCN, resulting in a reactivity profile spanning the entire RNA at each 
time point (Figure 4.2b).  Five sets of key interactions undergo large-scale structural 
changes during dimerization (Figure 4.2b, dashed blue regions). The two stem-loops, SL1 
and SL2 (positions 329-332 and 363-366), are unstructured in the monomer and form an  
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Figure 4.2 Time-resolved SHAPE analysis of MuLV dimerization. (a) Secondary structures 
of starting monomer and final dimer states. Nucleotides are colored by SHAPE reactivity. 
Key structural features are labeled, and boxes highlight known NC binding motifs. (b) Time 
course of MuLV dimerization. SHAPE reactivities are shown for monomer, dimer and 
representative intermediate time points. Key structural interactions are denoted with dashed 
blue lines. 
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intermolecular loop-loop kissing interaction in the dimer (Figure 4.2a, SL1 and SL2). A 
palindromic sequence, PAL1 (positions 210-219), is initially located within a reactive stem-
loop in the monomer, but forms a stable, unreactive, intermolecular duplex in the dimer 
(Figure 4.2a, PAL1). A second palindromic sequence, PAL2 (positions 283-298), initially 
located in a large flexible region in the monomer also forms a stable intermolecular duplex in 
the dimer (Figure 4.2a, PAL2). Conversely a stable stem, termed the anchoring helix 
(positions 231-251 and 290-315), transitions from a constrained to a more flexible state 
(Figure 4.2a, intermediates). 
I obtained reactivity data for every nucleotide within the 170 nt domain over sixteen 
one-second dimerization snapshots to yield over 2,700 structural data points. I grouped 
nucleotides exhibiting similar kinetic behaviors by k-means clustering,27 illustrated using the 
same coloring scheme used to indicate SHAPE reactivities on the secondary structures of 
the monomer and dimer states (Figure 4.2a). The dimerization profile is complex and 
involves seven kinetic behaviors, or clusters, involving four rates (Figure 4.3a and Table 
4.1). Although formally a bimolecular, or second-order process, all measureable rates are 
identical, within error, over a three-fold change in RNA concentration (Figure 4.4). The 
fastest measured process involved protection of nucleotides at the apex of SL1 and SL2 and 
was complete by the first time point and therefore occurs faster than ~5 min–1 (Figure 4.3a, 
cluster 1a). These observations are consistent with a model in which the first dimerization 
step involves rapid, nearly diffusion controlled, intramolecular interactions involving the SL1-
SL2 stem loops followed by a pseudo-unimolecular structural changes to form the mature 
dimer.  
Following the initial, rapid reduction in SHAPE reactivities involving the SL1-SL2 step 
loops, nucleotides in PAL1 also undergo rapid protection at an observed average rate of 1.6 
± 0.4 min-1 (Figure 4.3a, cluster 1b). Nucleotides in clusters 2 and 3 undergo a 
conformational change at the rate of 0.30 ± 0.03 min-1, but with two opposing behaviors, one  
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Figure 4.3 Model-free clustering of nucleotide-resolution profiles for dimerization. (a) MuLV 
RNA (600 nM) alone and (b) as facilitated by the retroviral NC protein (8 µM). Each data 
point is shown on a scale (black to red) corresponding closely to SHAPE reactivities. A 
representative kinetic curve and rate is shown for each cluster.  
 
 
SHAPE
 vs. time rate (min-1)
time (min)
0 .12 .25 .43 .62 1.0 1.5 2.0 3.0 5.0 8.5 12 18 30 45 60
time (min)
.12 .25 .43 .62 1.0 1.5 2.0 5.0 301510
1b
2
3
SHAPE
 vs. time
rate (min-1)
  1.6 +/-  0.3
0.0
naked RNA RNA + NC
1a
1b
2
3
4
5
6
7
a.  >5 
b.  1.6 +/-  0.4
0.3  +/-  0.1
  0.3  +/-  0.03
0.1 +/-  0.02
r
1
  1.6  +/-  0.28
r
2
  0.1  +/-  0.03
r
1
  1.6  +/-  0.1
r
2
  0.1  +/-  0.05
0.0
1a
a.  >5 
b.  1.6 +/-  0.4
a b
 76 
decreasing and the other increasing in net local nucleotide flexibility (Figure 4.3a).  These 
clusters include nucleotides in the anchoring helix and in PAL2, suggestive of a single 
process including both structures. Cluster 4, including nucleotides in the large flexible 
domain (nts 251 - 282), shows a statistically significant slower kinetic behavior with a rate 
constant of 0.11 ± 0.02 min-1. Finally, two clusters, 5 and 6, showed complex kinetic 
behavior in which the SHAPE reactivity either first increased and then decreased over time, 
or vice versa. These clusters reflect conformational changes occurring at the 1.6 and 0.1 
min-1 rates, consistent with nucleotides whose structures are influenced by a combination of 
the processes characterized by single rate constants (Figure 4.3a). 
In sum, time-resolved nucleotide-resolution analysis of MuLV dimerization 
emphasizes that this process is complex, slow, and characterized by multiple kinetically 
distinct transitions and intermediates.  
4.5 Nucleocapsid-mediated MuLV dimerization. 
We next performed an analogous set of experiments except that dimerization was 
initiated by addition of magnesium ion and the MuLV NC protein, a well-established and 
efficient RNA chaperone.4 The resulting SHAPE data were subjected to clustering and, 
strikingly, revealed that the NC protein collapsed dimerization into a single kinetic process 
occurring at 1.6 ± 0.4 min–1. Nucleotides involved in this process both decrease (cluster 1) 
and increase (cluster 2) in SHAPE reactivity; roughly half of the nucleotides show no change 
in shape activity during dimerization (Figure 4.3b).  Dimerization thus occurs in a single, fast 
transition in the presence of NC, with a complete apparent absence of the slow and multi-
rate processes that characterized the RNA-only reaction. 
To understand the profound contribution that NC makes to streamlining the 
dimerization reaction, we monitored NC binding immediately after combining the protein and 
RNA, corresponding to a ~2 sec time point. These experiments were performed in the 
absence of magnesium ion to reduce the rate of dimerization. The nucleotide-resolution  
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Table 4.1: Nucleotides ordered by model free clustering 
 
Cluster # 600 nM RNA nucleotides 600 nM RNA + 8 µM NC nucleotides 
1a 331, 332, 365, 366  332, 365, 366 
1b 209-211, 214-216, 229, 231, 232,  
237 
209-216, 238, 248-251, 265, 275, 
283, 284, 285, 287-289, 292, 294, 
295, 297, 328, 349, 350-352 
2 238, 240, 272, 284-290, 292, 296, 
298, 312, 329, 349, 368 
205-208, 217-219, 222-225, 228, 229, 
232, 233, 234, 239, 240, 241, 243, 
244, 245, 268, 270, 272, 302, 305, 
314, 315 
3 205-208, 223, 225, 226, 227, 233, 
235, 239, 241, 244-247, 295, 305-
309 
 
The rest 
4 217-220, 222, 224, 234, 243, 254, 
257,  265, 268, 270, 280, 283, 291, 
293, 300, 314, 315, 317, 318, 322, 
325-326, 328, 330, 335, 341, 323, 
348-352, 369 
 
5 251, 271, 313, 320-321  
6 237, 252, 258, 279, 299, 301, 311, 
344 
 
 
7 
 
The rest 
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effects of NC binding are readily detected in a difference analysis in which the SHAPE 
profile after NC binding is subtracted from that of the free RNA. Strikingly, of the 29 
nucleotides showing the largest changes in SHAPE reactivity, 19 (or 66%) correspond to 
guanosine residues (G labels, Figure 4.5a). Preferential binding to guanosine is consistent 
with studies showing that the MuLV NC protein contains a cleft that binds selectively to this 
nucleotide.28 Sites of protection (positive peaks, Figure 4.5a) likely correspond to stable 
binding during the 1 sec window of time-resolved SHAPE experiment; whereas, the smaller 
number of sites showing increased flexibility at guanosine residues in the presence of NC 
(negative peaks) likely reflect a rapid binding and release process.29 
4.6 A guanosine-to-inosine RNA variant accelerates native-like dimerization. 
One of the most physically profound features of nucleic acid structure are the special 
characteristics of base pairs involving guanosine. First, guanosine-cytosine base pairs are, 
on average, ~ 1 kcal/mol more stable than A-U pairs which corresponds to a factor of 
greater than 10 in equilibrium constant. Second, guanosine pairing is promiscuous and 
forms stable pairs with both cytosine and uridine.30,31 Both of these factors has the potential 
to increase the complexity of an RNA folding pathways by stabilizing non-native structures 
and by increasing the number of alternative base paired states, respectively. 
The strong preference of NC to interact at guanosine residues (Figure 4.5) coupled 
with these distinctive features of guanosine pairing prompted us to consider whether NC 
exerts its RNA chaperone activity by stabilizing interactions between guanosine and the 
other nucleotides. We therefore explored the dimerization reaction using an RNA in which all 
guanosine residues were replaced by inosine. Inosine-cytosine pairs are iso-structural, but 
roughly 1 kcal/mol weaker than guanosine-cytosine pairs and inosine does not pair stably 
with uridine (Figure 4.6a). 
The rate of dimerization of the inosine RNA was accelerated by 6-fold relative to that 
of the native RNA (Figure 4.1a,c).  Addition of NC protein had no effect on the rate of  
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Figure 4.4 Time-resolved SHAPE of MuLV RNA dimerization at 600 and 200 nM (labeled as 
in Figure 4.3). Model-free clustering analysis of both 600 and 200 nM MuLV RNA were 
compared with little to no concentration dependence. Clusters displaying slight rate 
differences (1b and 2) are boxed.  
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formation of the final state, although NC did resolve the apparent build-up of the PAL1 
intermediate (Figure 4.1d). 
We confirmed that the inosine RNA forms the same final dimer as the native RNA by 
probing the structure of the final inosine dimer by SHAPE. The inosine RNA forms 
essentially the same dimer structure and, moreover, the absolute nucleotide-resolution 
SHAPE measurements for the inosine and native dimers correlate strongly (R2 = 0.88) 
(Figure 4.6b). In strong contrast, the SHAPE reactivities of the inosine and native RNAs in 
the monomer state correlate poorly (R2 = 0.26) (Figure 4.6c), even though the two 
monomers fold into highly similar secondary structures. The inosine RNA monomer is 
destabilized by ~20 kcal/mol relative to the native sequence dimer. Strikingly however, 
addition of NC to the native sequence RNA yields a SHAPE profile that is highly similar to 
that of the inosine RNA (R2 = 0.87; Figure 4.6d). 
These data support the remarkable conclusion that a significant component of the 
RNA chaperone function of the MuLV NC protein can be explained by interactions that 
destabilize interactions between guanosine nucleotides and other positions in the RNA, that 
this function can be mimicked by simply substituting guanosine for the more weakly 
interacting inosine analogue, and that replacement of a single functional group in RNA 
(Figure 4.5a) can abrogate most of the RNA chaperone active of the NC protein. 
4.7 Discussion. 
4.7.1 The behavior of RNA in biology. 
Two fundamental features dominate the behavior of RNA in biology. First, full 
function requires that RNAs fold back on themselves to form information-rich structures that 
mediate biological interactions and carry out essential catalytic and recognition functions. 
Second, in perhaps the majority of cases, RNA molecules on their own fold incompletely, 
slowly, and by populating non-native intermediate states. These latter features are remedied 
by essential interactions with RNA chaperones. Substantial progress has been made in  
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Figure 4.5 Initial interactions between NC and the MuLV monomer. (a) A SHAPE difference 
plot illustrating the effect of NC binding after protein addition (0 ºC). Positive differences 
reflect nucleotides less flexible in the presence of NC. Differences greater than 20% are 
highlighted blue; of these, guanosine residues are labeled with a G.  
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understanding the mechanisms of ATP-dependent chaperone proteins32,33 and significant 
work has also defined the essential activities important for the function of the non-specific 
ATP-independent class of RNA chaperones.34,35 However, the molecular mechanisms by 
which generalized RNA chaperones facilitate RNA folding is not well understood. All RNA 
chaperone proteins ultimately function by facilitating structural re-equilibration reactions that 
allow an RNA to escape from stable, kinetically trapped states. 
4.7.2 Time-resolved SHAPE model of MuLV genomic dimerization. 
Only recently have RNA structural technologies made it possible to visualize how 
RNAs fold at nucleotide resolution in real time.36-38 Most RNA structural studies to date 
therefore have emphasized analyses of the initial and final RNA states and the relative 
populations of these states. Here, we have employed time-resolved SHAPE technology, 
coupled with model-free clustering, to create a full kinetic analysis of dimerization of a 
retroviral genome at nucleotide resolution in single-second snapshots. We use this data to 
develop a complete assembly model for retroviral dimerization and to decipher a mechanism 
for the interaction of retroviral genomic RNA with its nucleocapsid chaperone. 
Time-resolved SHAPE supports a model of MuLV genomic dimerization in which two 
MuLV monomers are rapidly brought together via loop-loop interactions at the 3' end of the 
dimerization motif and via a second loop-loop interaction at their 5' ends. The RNA-only 
model is complex: Seven distinct kinetic behaviors are observed and can be incorporated 
into a single unified model of MuLV RNA dimerization (Figure 4.7a). Upon magnesium 
addition, the SL1-SL2 stem loop-loop kissing interaction forms at the near-diffusion 
controlled limit (109 M-1min-1) and a second fast loop-loop interaction occurs that yields the 
PAL1 intermolecular duplex (1.6 min-1). A large-scale structural rearrangement, consistent 
with the observed mobility shift resolved by non-denaturing electrophoresis, creates the 
PAL2 duplex accompanied by melting of the anchoring helix (0.3 min-1). These fast events  
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Figure 4.6 Effect of inosine on RNA structure and on global conformation of the MuLV 
dimerization domain. (a) Watson Crick structure and free energy for G-C, I-C, and A-U base 
pairs. Correlations between (b) the inosine and native dimer, (c) the inosine and native 
monomer, and (d) the inosine monomer and native monomer 2s after NC addition. 
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then promote slower (0.1 min-1) small-scale interactions that create the final dimer.  This 
complex mechanism is transformed -- and greatly simplified -- in the presence of its 
biological chaperone for this process, the retroviral NC protein. RNA dimerization is 
accelerated by greater than ten-fold: The multistep dimerization process now occurs in a 
single kinetic step.  
4.7.3 A Guanosine-Centric Mechanism for RNA Chaperone Function. 
Previous work on MuLV dimerization has suggested that NC binds the retroviral RNA 
at guanosine residues.19,20 The critical clue in understanding the molecular mechanism of 
the chaperone function of NC was the observation that the initial interaction between NC 
and the MuLV RNA occurred predominately at guanosine residues, consistent with work 
showing NC contains a specific binding pocket for this nucleotide28 and substitution of 
guanosine residues within the NC-binding motif abrogates binding and packaging of this 
RNA in vivo.20  Single second snapshots taken after addition of NC to the MuLV monomer, 
show distinct changes in the reactivity profile concomitant with NC binding at flexible 
guanosine residues both within and outside of known NC binding motifs (Figure 4.5). An 
RNA variant, in which guanosine residues are substitute by inosine, dimerizes more 
efficiently than wt and is no longer affected by NC. From this, we infer a molecular 
mechanism for nucleocapsid-mediated dimerization in which NC binds to guanosine 
residues throughout the retroviral RNA dimerization domain and destabilizes interactions 
between this nucleotide and the rest of the RNA. NC binding both destabilizes slow-
resolving structures rich in guanosine and allows a great number of structures to form, and 
thereby facilitate more efficient reentry into the RNA folding pathway towards the final global 
free energy minima (Figure 4.7b). These results illustrate structural and mechanistic features 
likely to be common to many RNA chaperone-catalyzed processes. 
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Figure 4.7 Complete assembly model of MuLV retroviral dimerization. (a) The RNA-only 
model is complex. In the presence of NC, a copackaged RNA chaperone protein, the 
multistep dimerization process now occurs in a single fast kinetic step. (b) model for the 
folding free energy landscape of MuLV dimerization. 
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4.8 Experimental Procedures. 
4.8.1 Retroviral RNA transcripts. 
 The MuLV RNA construct is 331 nucleotides and spans the dimerization and 
packaging regulatory domain (~170 nts) including 5’ and 3’ flanking sequences of 46 and 
115 nucleotides, respectively.15,17 The transcript was synthesized and purified as 
described.20 
4.8.2 Time-resolved SHAPE. 
 In vitro generated MuLV RNA monomer transcripts (60 or 30 pmol, for the 600 nM 
and 300 nM reactions respectively) were renatured by heating at 95 °C for 3 min in 80 µL 
water and cooled on ice for 3 min. Monomers were then equilibrated at 37 °C for 3 min in a 
folding buffer without magnesium [50 mM HEPES (pH 7.5), 200 mM potassium acetate (pH 
7.5)]. The total reaction volume was 100 µL, sufficient for a 15-aliquot time course. A pre-
reaction (0 sec) time point was taken before magnesium addition to capture the initial 
monomer state.  Time-resolved SHAPE experiments were then initiated by the addition of 
MgCl2 to 5 mM (1 µL, 50 mM) at 37 °C and the RNA structure was interrogated over a time 
course spanning 7s to 1h. For each time point, SHAPE modification was performed by 
adding 9 µL (5.4 pmol) of the evolving MuLV RNA reaction to 1 µL BzCN (200 mM in 
DMSO), followed by vigorous pipetting to ensure mixing. Reaction with BzCN is complete 
within ~1s.22 A no-reaction control containing neat DMSO (1 µL) instead of BzCN was also 
performed. RNA was recovered using ethanol precipitation [2.5 vol ethanol, 1 µL glycogen 
(20 mg/mL); incubation at -20 °C for 60 min; and centrifugation at 20,000× g]. Pellets were 
resuspended in 6 µL 1/2× TE [5 mM Tris, 0.5 mM EDTA (pH 8.0)] buffer. The dimerization 
reactions were performed identically in the presence of a saturating amount of retroviral  
NCP10 protein (8 µM in 1 µL) except NC was added as a mixture with magnesium (2 µL 
total in mixture).  
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4.8.3 Primer extension. 
 The procedure has been described in detail previously17,39. MuLV primers [5'-
GGUGC ACCAA AGAGU CCAAA AGC-3' (LNA nucleotides are underlined), 5'-end labeled 
with 5-FAM or 6-JOE] bind 3' of the the MuLV dimerization domain (nucleotides 422 to 445). 
Primers (1 µL; 10 pmol) were annealed to the MuLV RNA (6 µL; 5.4 pmol in 1/2× TE buffer) 
by heating at 65 °C and 45 °C for 5 min each and then snap-cooled on ice. Reverse 
transcription buffer [3 µl; 200 mM Tris (pH 8.0), 250 mM KCl, 10 mM MgCl2, 2 mM each 
dNTP, 20 mM DTT] was added at 0 °C, and primer extension was performed with 
Superscript III (Invitrogen) reverse transcriptase (0.5 µl; 100 U) at 45 °C for 1 min, followed 
by incubation at 52 °C and 65 °C, for 10 min each. Reactions were quenched by cooling to 4 
°C and addition of 3 M sodium acetate (pH 5.2). A sequencing marker was generated by 
adding 0.5 µL ddGTP (10 mM) to the primer extension reaction mixture using unmodified 
RNA. The 1M7 and DMSO control reaction mixes were each combined with equal amounts 
of ddGTP-terminated sequencing ladders, precipitated with ethanol, and resuspended in 
deionized formamide (10 µl). cDNA fragments were resolved on an Applied Biosystems 
3130 capillary electrophoresis instrument. 
4.8.4 Data processing and structure prediction. 
 Time-resolved SHAPE data was processed using fully automated software for the 
quantification of SHAPE data (QuShape). The initial raw sequence trace was corrected for 
dye variation and signal decay; and peak intensities were scaled, aligned, integrated, and 
normalized using a suite of optimized statistical algorithms. The net result of this software-
facilitated analysis is an accurate and efficient quantification of SHAPE data (total analysis 
time for a single SHAPE trace is approximately 3 minutes). After successful analysis of this 
first (reference) trace, subsequent time points were analyzed automatically by alignment to 
the saved project file as a reference trace.  Each CE separation contained a reaction 
performed in the presence or absence of 1M7 (labeled with FAM) and a sequencing reaction 
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(labeled with JOE), performed using ddGTP. To develop secondary structure models for 
intermediate states, SHAPE reactivity information was used to impose a pseudo-free energy 
change constraint in conjunction with nearest neighbor thermodynamic parameters.40 
4.8.5 K-means clustering. 
 Analyzed SHAPE data were sorted by individual nucleotide kinetic behaviors in an 
automated way using GeneCluster software.27 Files are uploaded as tab delimited text files 
using specific headings as described in the manual.41 I have included a few nuances I used 
to commandeer the software for kinetic SHAPE clustering here. One, under the k-means 
tab, I organized the data by genes (or rows) and systematically cycle through the number of 
clusters (starting at 10 and reducing the cluster number by one each cycle) until a minimal 
set of clusters are created that define the data (i.e. you are splitting the noise). Two, under 
the adjust data tab, I used the normalize genes option by clicking the appropriate box and 
clicking apply. Three, I used the absolute correlation (uncentered) similarity metric to 
organize the genes. Four, click execute. The clustering analysis is performed and a file is 
loaded in the same folder that the data is opened from. Clusters are visualized using 
TreeView software.27  
4.8.6 Non-denaturing electrophoretic mobility shift assays of MuLV dimerization. 
 MuLV wild type (wt) dimerization domain RNA internally labeled with [32P] (~0.5 nM) 
was mixed with unlabeled RNA (200 or 600 nM in 20 µL). For the inosine variant RNA, 
synthesis by transcription was performed in the presence of inosine triphosphate instead of 
guanosine triphosphate. Reactions were treated exactly as per the time-resolved SHAPE 
experiments, outlined above. Briefly, samples were heated to 95 °C, rapidly cooled on ice, 
and equilibrated with a folding buffer without magnesium [50 mM HEPES (pH 7.5), 200 mM 
potassium acetate (pH 7.5), at 37 °C]. The reaction was initiated by addition of 1 µL of 5 mM 
MgCl2 and placement at 37 °C. Time points (3 µL) were mixed with 3 µL of 30% (v/v) 
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glycerol (containing marker dyes), loaded directly onto the non-denaturing gel (5% 
polyacrylamide in TBE), and resolved by electrophoresis at 4 °C for 2 h at 20 W. 
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